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Abstract
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A thesis submitted in partial fulfillment of the requirement of the degree of Master of Science at
Virginia Commonwealth University
Virginia Commonwealth University, 2020
Major Director: Eric G. Benotsch, Ph.D.
Associate Professor of Psychology
Department of Psychology
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Background: Gender minorities encounter a myriad of barriers to accessing general and gender
affirming healthcare. Financial disparities impacting affordability of healthcare costs and
insurance-based denials for gender-affirming care are among prominent barriers discussed.
Considerations of the prevalence of stigma, discrimination, and erasure of gender minority
identities must not be neglected when seeking to understand healthcare accessibility and
utilization in this population. Previous researchers have examined gender minority patients’
experiences of discrimination in healthcare settings and delaying care due to fear of
discrimination. There is a dearth of knowledge about the relationship between lifetime exposure
to varied forms of healthcare discrimination and healthcare avoidance behaviors; potentially
resulting in health disparities in this population. The purpose of this study was to examine the
relationship between perceived lifetime healthcare discrimination and healthcare avoidance in
the past year and since the start of the coronavirus pandemic due to anticipated discrimination in
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a gender minority sample. This study also evaluated the relationship between perceived
healthcare discrimination and anxiety and depressive symptoms in this population. Method: The
gender minority sample (N = 342) was recruited using an online recruitment platform.
Participants responded to inquiries related to their demographic information, experiences of
gender identity-related discrimination in healthcare, healthcare utilization, and mental health
symptoms. Results: The majority (78.1%) of participants reported being exposed to at least one
form of healthcare discrimination in their lifetime, though participants reported experiencing an
average of almost two and a half (M = 2.43) distinct forms of healthcare discrimination. Most
(64.9%) participants reported that the medical forms that healthcare providers asked them to
complete were not inclusive of their gender identity at least once in their lifetime and 43.5%
reported having to teach a healthcare provider about gender minority identities in order to receive
appropriate healthcare. More than a fourth (26.3%) of participants reported avoiding needed
healthcare in the past year and 16.1% since the start of the coronavirus pandemic due to
anticipated discrimination in healthcare settings because of their gender identity. A majority of
the sample scored at or exceeded the clinical thresholds (³7) on the depression (73%) and
anxiety (62%) Brief Symptom Inventory subscales. Hierarchical logistic regression analyses
showed that healthcare discrimination significantly predicted healthcare avoidance in the past
year, χ2 (1) = 44.14, p < .001, OR = 1.54, 95% CI [1.35-1.75], p < .001, and since the start of the
coronavirus, χ2 (1) = 36.27, p < .001, OR = 1.55, 95% CI [1.34-1.78], p < .001, over and above
five demographic variables (age, race, income, insurance coverage, and disability/neurodivergent
identity status). Participants were 54% more likely to avoid needed healthcare in the past year
and 55% more likely since the start of the coronavirus as their exposure to distinct types
healthcare discrimination increased. Healthcare discrimination significantly predicted anxiety,
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∆R2 = .084, ∆F (1, 338) = 32.17, p < .001, and depressive symptoms, ∆R2 = .044, ∆F (1, 338) =
16.09, p < .001, over and above two demographic variables (age and race). Discussion: These
findings suggest that healthcare avoidance incited by exposure to gender identity-based
healthcare discrimination and erasure is a prominent barrier perceived by transgender and gender
independent individuals to accessing healthcare generally and during a global pandemic.
Conclusion: The adoption and implementation of healthcare inclusion initiatives and policies
would be supportive of increasing equitable access to and utilization of healthcare for
transgender and gender independent individuals.

Keywords: transgender, healthcare discrimination, healthcare utilization, anxiety, depression,
Coronavirus
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The Harm in Seeking Care
Assessing the Relationship Between Healthcare Discrimination and Healthcare Avoidance
Behaviors in the Past Year and Since the Start of the Coronavirus Pandemic in a Transgender
and Gender Independent Sample
Introduction
The visibility and prevalence of gender minority individuals has increased in recent
years, leading to the proliferation of empirical research regarding the biological, psychological,
and social experiences of this population. Despite their increased visibility in multiple societal
contexts and in existing health and psychology research literature, gender identity related
discrimination and marginalization is prevalent in almost every institutional, systematic, and
social domain that gender minorities engage with, including healthcare settings. Stigma,
discrimination, and erasure of gender minority identities in healthcare settings serve as central
barriers in accessibility and utilization of healthcare for gender minority patients (Bauer et al.,
2009; Bauer et al., 2014; Bauer et al., 2015; Bradford et al., 2013; Grant et al., 2011; Jaffee et al.,
2016; James et al., 2016; Macapagal et al., 2016; Puckett et al, 2020; Rodriguez et al., 2017;
Seelman et al., 2017; Shires & Jaffee, 2015; White et al., 2015). Gender minority patients
represent a vulnerable tier of health care consumers facing distinct direct and indirect forms of
discrimination in healthcare settings including healthcare providers’ lack of knowledge about
gender minority identities and healthcare needs, verbal and physical harassment, abuse, and
denial of care (Bakko & Kattari, 2020; Cruz, 2014; Grant et al., 2011; James et al., 2016,
Rodriguez et al., 2017). Several studies have reported that gender minority individuals delay or
avoid needed healthcare due to fears of discrimination (Cruz, 2014; Grant et al., 2011; Jaffee et
al., 2016; James et al., 2016; Kattari et al., 2019; Lykens et al., 2018; Seelman et al., 2017; White
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et al., 2015). To the author’s knowledge, no studies have sought to investigate the culmination of
various forms of reported lifetime healthcare discrimination as a predictor for healthcare
avoidance due to anticipated discrimination in gender minority individuals. The aim of the
present study is to evaluate the relationship between reported lifetime healthcare discrimination
and healthcare avoidance in the past year and since the start of the coronavirus pandemic due to
anticipated discrimination among gender minorities. The present study also seeks to evaluate the
relationship between perceived healthcare discrimination and anxiety and depressive symptoms
in this population.
Terminology
The term gender minority refers to transgender and gender nonconforming individuals
whose gender identities, gender roles, and gender expressions do not align with or conform to the
gender norms associated with their natal (birth) sex (Hendricks & Testa, 2012). The terms
transgender and gender nonconforming (TGNC) are referred to as umbrella terms - this
terminology is often considered to be inclusive of and used to signify the vast spectrum of
identities that exist within this community, although not all individuals within this community
use this terminology to describe their gender identity. In an effort to not reinforce gender
binarism (i.e., the idea that gender identity must solely and distinctly conform to assigned natal
sex; Krieger, 2020) and to affirm the wholeness and the internal knowing of gender embodied in
individuals within this community, I will refer to this population as transgender and gender
independent for the remainder of this thesis. The term gender independent has been used in
previous literature regarding this population in Canada (Pyne, 2014) and Australia (Zappa,
2017). Transgender and gender independent individuals are those who may have been assigned a
female natal sex and identify more closely with masculinity and seek congruity anatomically and
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psychologically (FTM), assigned a male natal sex and identify more closely with femininity and
seek congruity anatomically and psychologically (MTF), and those individuals who were
assigned a male, female, or intersex natal sex and whose gender identities align with neither,
both, or an amalgamation of masculinity and femininity who may or may not seek congruity
anatomically and psychologically (e.g., gender nonbinary, genderqueer, androgynous, neutrois,
etc.). This range of gender identities and conceptualization of the variance in the relationship
between natal sex and gender identity varies away from historical constructs regarding gender
(American Psychological Association, 2015).
Prevalence of Transgender and Gender Independent Identities
In a meta-analysis, Meerwijk & Sevelius (2017) examined national population-based
surveys published from 2006 to 2016 to estimate the population size of transgender individuals
in the United States. Their study indicated that for every 100,000 adults in the United States that
390 (0.39%) identify as transgender – equating to almost 1 million Americans (Meerwijk &
Sevelius, 2017). In a similar analysis of surveys published from 2009 to 2011, with a specific
focus on the transgender and gender independent population in Massachusetts, it was estimated
that 0.5% of the adult population surveyed (ages 18 to 64 years) identified as transgender and/or
gender independent (Conron et al., 2012). These studies depict that there is a significant
proportion of individuals in the United States population who have a transgender or gender
independent identity. The prevalence of this population may be much higher than previous
research has been able to distinguish and articulate due to informational erasure, the prominent
use of convenience samples, and the methodological reliance on explicit (self-report) survey
measures or on the identification of individuals in this population from medical charts and
diagnostic coding within clinical and healthcare settings. Some individuals in this population
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may be aware of their gender variance and yet do not identify as a transgender (i.e., transgender
is rarely an option given, but even when it is a choice it may not be representative of an
individual’s gender identity), some may not seek congruity with their gender identity and their
anatomy or may not have access to seek the support of medical treatment for congruity and
gender affirming procedures, and others may not find that being visible or represented in
healthcare settings and research is liberating or even possible.
Historical Perspective of Gender Identity
Historically in the United States, sex (biological structures of what is categorized as male
or female – sex chromosomes, hormones, and internal and external genitalia identified at birth)
has been conflated with gender (existing in a role that is girl/woman/female or boy/man/male in
accordance with socially designated behavior and personality patterns), and gender roles with
gender expression (presentations of masculinity and femininity through physical expressions,
clothing, and verbal/physical gestures and behaviors) (American Psychiatric Association, 2013).
The conflation and assertions of a biological orientation of sex to gender has resulted in a binary
and cisnormative view of gender identity – that gender identity is uniformly aligned with an
individual’s assigned natal sex and that all people conceptualize their identities in this manner.
The APA (2015) defines gender identity as an individual’s “deeply felt, inherent sense of being a
boy, a man, or male; a girl, a woman, or female or an alternative gender that may or may not
correspond to a person’s sex assigned at birth or to a person’s primary or secondary sex
characteristics” (p. 862).
Gender Dysphoria
The APA’s (2013) Diagnostic and Statistical Manual of Mental Disorders 5th edition
(DSM-5) acknowledges the variances that individuals experience in gender identity development
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and describes the distress that can be associated with gender variance as Gender Dysphoria.
Gender dysphoria is defined as the distress that is associated with “a marked incongruence
between one’s experienced/expressed gender and assigned gender” (APA, 2013). The description
of gender dysphoria acknowledges that transgender and gender independent individuals’
experiences of distress that are associated with the incongruence felt between their natal sex and
gender identity is not stagnant; that the degree of distress that individuals feel may be in some
degree impacted by the perceptions or misperceptions (i.e., being misgendered) of others
regarding their gender identity and their autonomy in, access to, and use of social, psychological,
and/or physical affirmations of their gender identity should they seek it (APA, 2013). The
development of the diagnosis of gender dysphoria may have provided transgender and gender
independent individuals a route to affirmation, validation, and the ability to access necessary
psychological and physical health care and support. However, its inclusion at times has resulted
in exploitation, stigma, discrimination, and bias that has impacted transgender and gender
independent patient control and serves as a barrier in transgender and gender independent
patients’ ability to advocate for themselves and for the relationship they would like to have with
their minds and bodies (Lev, 2009). Whether or not a transgender or gender independent
individual has a gender dysphoria diagnosis or seeks provider or insurance approval for gender
affirming mental or physical health interventions (e.g., therapy, hormone replacement therapy,
gender affirming surgeries) they should be treated with competent and compassionate care.
Health care professionals should rely on standards of care such as the World Professional
Association for Transgender Health’s (WPATH) Standards of Care for the Health of
Transsexual, Transgender, and Gender Nonconforming people (Coleman et al., 2012) for
guidance, when their organization does not have inclusive and affirming standards to guide them
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– rather than continue to perpetuate incompetent, stigmatizing, and discriminatory practices.
Stigma and discrimination can have an immensely harmful impact on an individual’s health and
well-being and may result in minority stress (Frost & Meyer, 2009).
Minority Stress Model
The Minority Stress Model (Meyer, 2003) - initially formulated to consider the minority
stress processes of the Lesbian, Gay, and Bisexual population; is facilitative in interpreting why
transgender and gender independent individuals experience heightened distress. Applications of
the minority stress model have been applied to the transgender and gender independent
population (Hendricks & Testa, 2012; Testa et al., 2015). The model examines the three
processes through which transgender and gender independent individuals are vulnerable to
socially induced stress; distal stressors, interactive proximal stressors, and internalized proximal
stressors. Distal stressors are those that are external and observable such as transgender and
gender independent individuals’ experiences with discriminatory, stigmatized, and violent
behaviors in multiple societal domains – to include health care settings (e.g., a doctor or nurse
refusing to use the patient’s preferred pronoun). Interactive proximal stressors are the processes
by which transgender and gender independent individuals develop a heightened vigilance in
anticipation and expectation for rejection, discrimination, stigma, and violence (e.g., a
heightened fear of verbal harassment in a health care setting due to experiencing or witnessing
verbal harassment in the past). Internalized proximal stressors are demonstrative of the
psychological processes that occur for transgender and gender independent individuals when
they internalize the rejection and negative social demeanors that may result in concealment of
their gender identity, internalized transphobia, detrimental mental health outcomes, inefficacious
coping strategies such as non-medical use of prescription drugs (Benotsch et al., 2013) or
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avoidance of needed health care (Bauer et al., 2014; Jaffee et al., 2016; James et al., 2016;
Macapagal et al., 2016; Seelman et al., 2017). Researchers have assessed various facets of
minority stress and resilience pathways that may transcend the negative health outcomes that
exist as a result of socially induced stress such as elevated self-esteem and identity acceptance,
social support, and advocacy for the reduction and/or elimination of stigmatized and
discriminatory policies that exist within social systems (Bariola et al., 2015; Barr et al., 2016;
Meyer, 2015). The minority stress model has been a predominant conceptual framework through
which researchers have explained the heightened levels of stress and adverse health outcomes
that transgender and gender independent individuals experience as a result of chronic, complex,
and high levels of gender identity-related stigma, prejudice, and discrimination (Flentje et al.,
2019; Meyer, 2020).
Psychological Distress
A number of empirical studies have articulated noteworthy findings regarding the
elevated levels of psychological distress reported by transgender and gender independent
individuals related to experiences of minority stress (e.g., discrimination, stigma, and violence)
(Barzagan & Galvin, 2012; Bockting et al.., 2013; Clements‐Nolle et al., 2006; Dispenza et al.,
2012; James et al., 2016; Rotondi et al., 2011; Staples et al., 2018; Tebbe & Moradi, 2016; Testa
et al., 2017, 2015). Exposure to minority stress has been found to be related to a myriad of
mental health concerns including depression (Barzagan & Galvin, 2012; Bockting et al., 2013;
Dispenza et al., 2012; Puckett et al., 2019; Puckett et al., 2020; Rotondi et al., 2011), anxiety
(Bockting et al., 2013; Borgogna et al., 2019; Puckett et al., 2019; Puckett et al.., 2020), and
suicidality (Clements‐Nolle et al., 2006; Dickey & Budge, 2020; James et al., 2016; Staples et
al., 2018; Testa et al., 2017). Studies have also explored associations between exposure to
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discrimination and internalized stigma (Meyer, 2003; Watson et al., 2019); which when
combined with experiences of external discrimination and violence may result in psychological
exhaustion, concern for physical and psychological safety, anticipation for future discriminatory
experiences, and avoidance of spaces that may result in discrimination and/or victimization
(Puckett et al., 2018; Rood et al., 2016). Though researchers have clearly articulated the
deleterious psychological distress that transgender and gender independent individuals
experience driven by their experiences of discrimination, stigmatization, and marginalization;
less is known about the relationship between experiences of health care discrimination and
psychological symptoms experienced by this population. The current study aimed to evaluate the
relationship between perceived health care discrimination and anxiety and depressive symptoms
in a sample of transgender and gender independent individuals.
Erasure
Though direct and visible forms of stigma and discrimination are important to consider
when examining the ostracism associated with deleterious health outcomes in transgender and
gender independent individuals, erasure is an additional distinct function that is supportive in
understanding the intricate systematic, structural, and institutional exclusion that makes this
population vulnerable in healthcare settings (Bauer et al., 2009). A qualitative analysis conducted
by Bauer et al (2009) further conceptualized two distinct ways that erasure in healthcare impacts
transgender and gender independent individuals - informational and institutional erasure.
Informational erasure refers to the deficit in knowledge advanced about the experiences of
transgender and gender independent individuals and the assumption that such knowledge does
not exist, when there is evidence of people who have these identities and experiences (Bauer et
al., 2009). Informational erasure can also be conceptualized in terms of gender identity data not
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being routinely collected in population surveys (e.g., The U.S. Census); in contrast, data on natal
sex is often collected in most population and health surveys. Institutional erasure refers to a lack
of policy and structure in organizations and systems to at the very least accommodate, protect or
affirm gender minorities (e.g., public restrooms and accommodations being designated for
men/women, or medical intake forms that utilize binary framing sex categories). Transgender
and gender independent individuals’ susceptibility to direct and indirect forms of informational
and institutional erasure serve as barriers in accessibility and engagement with healthcare (Bauer
et al., 2009). The current study aimed to understand this population’s experiences of erasure
when engaging with healthcare providers.
Healthcare Discrimination
Existing studies have reported disturbingly high patterns of societal discrimination in
education, housing, employment, legal protection and support, public accommodations, and
access to quality healthcare (Grant et al., 2011, James et al., 2016; McCann & Brown, 2017).
Grant et al (2011) and James et al (2016) identified inequalities in education and employment as
barriers to healthcare access, amidst the discrimination that transgender and gender independent
individuals face in healthcare when they are able to access it. Transphobia (i.e., irrational fear
and/or hatred of transgender and gender independent individuals) and cisgenderism (i.e.,
systemic bias based on the idea that all people are cisgender, thereby leading to prejudicial
beliefs and behaviors toward transgender and gender independent individuals) contribute to the
violence and discrimination that transgender and gender independent individuals are exposed to
in structural systems including education, thereby contributing to the inequities this population
faces in employment impacting their ability to cover healthcare costs (Grant et al., 2011; James
et al., 2016). Rodriguez et al (2017) assessed discrimination in health care settings among
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transgender and gender independent identified individuals (N = 6,106) in the United States
related to their recognizability as a transgender or gender independent. Almost half (49%) of the
participants in the study reported that they are always, most of the time, or some of the time
recognized as a transgender and/or gender independent. Experiences of discrimination in health
care was reported by 33.1% of the participants. The researchers in the study found that there was
a significant relationship between being recognized as transgender and/or gender independent to
any extent and perceived discrimination in healthcare settings, with discrimination being most
prevalent in participants who reported being recognized as transgender or gender independent
always (40.9%) and most of the time (36.9%). In a similar study Shires & Jaffee (2015)
examined the factors associated with health care discrimination against FTM identified
individuals (N = 1,711) in a secondary analysis of the National Transgender Discrimination
Survey (Grant et al., 2011). The researchers in the study found that 41.8% of the participants
reported verbal harassment, physical assault, or denial of equal treatment and care in a doctor’s
office or hospital. The researchers in the study also found that being a racial/ethnic minority,
sexual minority, having a lower education level, living in a specified non-binary gender identity,
using hormonal and surgical treatments, and having identification documents where gender
identity and natal sex were not aligned was associated with increased reporting of health care
discrimination experiences. The discrimination and disparities articulated in this study were
consistent with the findings in James et al.’s (2016) U.S. Transgender Survey findings of high
levels of mistreatment and discrimination when seeking healthcare among a national sample of
transgender and gender independent individuals (N = 27, 715). One-third (33%) of the
participants who engaged with a health care provider had at least one negative experience related
to being transgender and/or gender independent, with higher negative experiences reported when
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participants reported intersecting minority identities. Additionally, James et al (2016) reported
that 33% of participants did not see a health care provider when it was necessary due to their
inability to afford the care, and 23% of participants reported avoiding health care services when
it was necessary in the year prior to the completion of the self-report survey. Although
researchers have described the prevalence of individual forms of healthcare discrimination (e.g.,
refusal or denial of trans-related care) using dichotomous variable responses (e.g., yes or no), to
the author’s knowledge no studies have evaluated the culmination of varying forms of healthcare
discrimination across multiple forms of healthcare discriminatory experiences. The current study
investigated the predictability of mental health outcomes and healthcare avoidance behaviors
related to perceived healthcare discrimination.
Healthcare Avoidance
Researchers have begun to further investigate the avoidance and delaying of engagement
in needed care due to the prevalence of stigma, discrimination, and erasure of transgender and
gender independent identities in health care (Bauer et al., 2014; Bauer et al., 2015; Bradford et
al., 2013; Jaffee et al., 2016; Macapagal et al., 2016; Seelman et al., 2017). Seelman et al (2017)
examined whether or not non-inclusive healthcare and fear-based delaying or avoiding
healthcare would predict poorer healthcare outcomes in a sample (N = 417) of transgender and
gender independent adults in the Rocky Mountain region of the United States. The researchers in
the study found that participants who delayed healthcare due to their fear of discrimination had
worse general health than those who did not delay care (B = 0.26, p < .05), and that they were
also at a 3% greater risk for anxiety and depression symptoms, a 4% greater risk of a past year
suicide attempt, and 3% greater risk of past year suicidal ideation. In addition to fear of
discrimination, researchers have also reported avoidance or delays in seeking care due to other
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factors such as fear of discrimination due to an intersecting sexual minority identity (Macapagal
et al., 2016), intersecting cultural identities (Bradford et al., 2013), and perceived provider
sensitivity to and knowledge of transgender and gender independent identities and concerns
(Bauer et al., 2015; Jaffee et al., 2016). The findings of these studies articulate fear of
discrimination and consequent avoidance and delay of care as a dominant factor in health care
challenges faced by transgender and gender independent identities. The current study
investigated the relationship between perceived healthcare discrimination and avoidance of
healthcare due to anticipated discrimination in the past year and since the start of the coronavirus
pandemic.
The Coronavirus Pandemic
On March 11, 2020 the World Health Organization (WHO) declared the coronavirus
outbreak a global pandemic (WHO, 2020). In response to that declaration, U.S. federal and state
governments began to close or restrict access to public entities and issue guidance to the public
to mitigate the spread of the coronavirus. The Centers for Disease Control and Prevention (CDC)
issued guidance to state and local governments, primary and secondary schools, institutions of
higher education, nursing homes, and individuals to limit community transmission by
discouraging interaction between individuals outside of their homes, advising individuals to
practice social distancing when interacting in public spaces, and encouraging the use of face
coverings when entering indoor spaces (CDC, 2020a, b). In combination with the novelty of the
coronavirus pandemic and the marginalization of the Lesbian, Gay, Bisexual, Transgender, and
Questioning (LGBTQ+) community there is a dearth of knowledge regarding the impact that the
coronavirus has had on the LGBTQ+ population generally. Researchers have highlighted
potential individual, structural, and social challenges faced by LGBTQ+ populations in the

20
context of the coronavirus pandemic (Salerno et al., 2020). Gonzalez et al (2020) evaluated the
mental health needs of LGBT college students in the U.S. during the coronavirus pandemic. The
study found that approximately 60% of the sample (N = 477) reported experiencing
psychological distress, anxiety, and depression during the pandemic. To the author’s knowledge,
there have been investigations of the impacts of the coronavirus pandemic on psychological
health outcomes among individuals in this population (Hawke et al., 2021; Hunt et al., 2021;
Kidd et al., 2021; Moore et al., 2021), but none have investigated the physiological health
impacts of the pandemic on transgender and gender independent individuals. The current study
evaluated the relationship between perceived experiences of healthcare discrimination and
avoidance of healthcare due to anticipated discrimination since the start of the pandemic.
The Present Study
The aim of the present study was to evaluate the relationship between reported lifetime
healthcare discrimination and healthcare avoidance in the past year and since the start of the
coronavirus pandemic due to anticipated discrimination among transgender and gender
independent individuals. Although previous research has examined this population’s experiences
with discrimination in healthcare settings and delaying healthcare due to fear of discrimination,
no studies have examined the culmination of varied forms of discrimination as a predictor for
healthcare avoidance behaviors due to anticipation of discrimination, or psychological distress.
The present study also evaluated the relationship between perceived healthcare discrimination
and anxiety and depressive symptoms in this population.
Hypothesis 1a-1b: I hypothesize that perceived healthcare discrimination will
significantly predict past year healthcare avoidance due to anticipated discrimination among
transgender and gender independent individuals. I also hypothesize that perceived healthcare
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discrimination will significantly predict past year healthcare avoidance due to anticipated
discrimination after accounting for other factors that may contribute to healthcare avoidance
behaviors including age, race/ethnicity, income, disability/neurodivergent identity status, and
health insurance coverage.
Hypothesis 2a-2b: I hypothesize that perceived healthcare discrimination will
significantly predict healthcare avoidance since the start of the coronavirus due to anticipated
discrimination among transgender and gender independent individuals. I also hypothesize that
perceived healthcare discrimination will significantly predict healthcare avoidance since the start
of the coronavirus due to anticipated discrimination after accounting for other factors that may
contribute to healthcare avoidance behaviors including age, race/ethnicity, income, health
insurance coverage, and disability/neurodivergence identity status; and symptoms of
coronavirus.
Hypothesis 3: I hypothesize that perceived healthcare discrimination will significantly
predict anxiety symptoms after accounting for other factors that may predict anxiety symptoms
including age and race/ethnicity.
Hypothesis 4: I hypothesize that perceived healthcare discrimination will significantly
predict depression symptoms after accounting for other factors that may predict depression
symptoms including age and race/ethnicity.
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Method
Procedures
The data for this study were derived from participant responses to a survey administered
online from June 25 to July 4, 2020. The participants were recruited using Prolific, an online
research participant recruitment platform that connects social, economic, and political science
researchers with their intended research demographic. Researchers have found that Prolific offers
a more transparent and protective research environment for participants and researchers, higher
data quality, and higher levels of participant naivety and diversity when compared with other
online research recruitment platforms (Palan and Schitter, 2018; Peer et al., 2017). Several steps
were taken to ensure the quality of the data collected in this online survey: (a) participants had to
complete prescreening demographic information via their Prolific profile to be considered for the
study; specifically the information that participants reported regarding their natal sex and current
gender identity when creating their initial Prolific research participant profile was used to only
invite those that did not identify as cisgender, (b) IP addresses were examined to ensure that
participants were in the United States and to support in the identification of any potential
duplicate responses, (c) the survey platform included survey protection options that allowed the
participants’ anonymous Prolific IDs to be recorded for support in identifying potential duplicate
responses, (d) participants were required to accurately complete a CAPTCHA challenge to
inhibit programmed responses (e.g., participants were prompted to check a box stating “I’m not a
robot” and accurately identify items within a gridded photo), and (e) participants were required
to answer five questions positioned within the survey to assess their attention to what survey
questions were asking of them and had to accurately complete four of the five attention checks to
be included in study analysis (e.g., Please select “neither agree nor disagree” for this item.).
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These attention checks were also supportive of disqualifying participants who were being
potentially impetuous or randomly responding to survey questions.
Participants were required to meet the following criteria to be eligible to participate in
this study: (a) be 18 years old or older, (b) identify as transgender or gender independent (e.g.,
Transgender, Gender non-conforming, Non-binary, Genderqueer, Gender fluid, and other gender
identities that vary away from the historical binary lens of gender), (c) have the ability to
complete the anonymous self-administered online Prolific survey in English, and (d) have an
approval rating of 95 percent or above in prior research studies participated in through the
Prolific platform. In total, 368 individuals accessed the online survey after qualifying to
participate in the study based on their responses to a Prolific demographic screener
questionnaire. Ninety-three percent (n = 342) of the individuals who accessed the survey were
retained for this study’s analyses. The remaining 7% (n = 26) were disqualified from the study as
a result of a variety of factors: inaccurately responding to the CAPTCHA challenge (n = 7), not
completing any questions beyond the CAPTCHA challenge (n =5), inaccurately answering more
than one of the five attention check questions (n = 1), only completing the portion of the survey
not inclusive of gender identity and natal sex questions (n =2), and reporting what would appear
to be a cisgender identity – making them ineligible to participate in the study (n = 11).
Participants were prompted to review a consent document prior to accessing the survey
(see Appendix A). Once consent was obtained and the CAPTCHA question was accurately
answered participants were asked to respond to inquiries regarding demographic information,
experiences of gender-related discrimination in healthcare and in other contexts, healthcare
engagement or avoidance behaviors, mental health symptoms, resiliency factors, substance use
behaviors, and coronavirus impacts. In total, the survey consisted of 112 items (survey

24
respondents may have engaged with fewer items due to skip patterns throughout the survey) and
took participants an average of 13 minutes to complete. Upon completion of the survey
participants received compensation for their time in the amount of $1.20. The current study’s
materials and procedures were approved by Virginia Commonwealth University’s Institutional
Review Board.
Sample
The final sample (N = 342) includes transgender and gender independent respondents
from 42 of the United States of America and the District of Columbia. The predicted population
for 2019 from the U.S. Census Bureau (2019) was found to be strongly correlated with the
number of participants from each state, r(49) = .95, p < .001. On average, participants were 25.8
years old (Standard Deviation = 7.2, Range = 18 – 59 years). The sample reported a diverse
range of gender identities. Just over half of the sample identified as either Non-binary (39.2%) or
Trans Man (12.3%), and the other half of the sample reported gender identities including Trans
Woman, Man, Woman, Gender Fluid, Genderqueer, Gender Non-Conforming, or another
identity not listed. A total of 32 participants reported that their gender identity was not listed
among the survey options. Examples of the written responses for those participants included:
Agender, Bigender, Transmasculine, Transmasculine non-binary, and other individually listed
identities (e.g., “Demi-boy”, “Demigirl”, “Intersex AFAB Trans Masc Non-binary”). An
assigned female natal sex was reported by the majority (72.1%) of the sample. Over half of the
sample reported a sexual orientation that was either Bisexual (33.3%) or Pansexual (22.8%). A
total of 29 participants reported that their sexual orientation was not listed among the survey
options. Some examples of the responses participants entered include: Queer, Asexual, and
Demisexual. The majority of participants identified as Non-Hispanic White (68.7%) with low
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levels of annual income (57% of participants reported that they earned less than $40,000 per
year). Slightly less than half of the sample reported that the highest level of formal education
they attained was High School (43%) or GED (6.4%). Employment status varied among the
sample with over half of the sample being unemployed (33%) or Students (28.9%). The majority
of the sample reported having health insurance (80.7%) and were more frequently covered under
private healthcare plans (67.4%). More than half of participants indicated that they have
primarily lived with parents/siblings (40.4) or a partner (24.0%) during the past year. Sixty-five
percent of participants reported that their daily activities are limited in some way due to their
physical, mental, or emotional health. Just over half of the sample identified as disabled and/or
neurodivergent (52.6%). Though only a small number of participants (n = 33) reported using
assistive equipment or technologies (e.g., a mobility device, wheelchair, screen reader,
captioning software, etc.) this is important to note. A complete description of demographic
information for the sample is presented in Table 1.
Table 1: Sample Demographics
Demographic Characteristics
Assigned Natal Sex

n (%)

Female
Male
Gender Identity

246 (72.1)
95 (27.9)

Non-Binary
Trans Man
Trans Woman
Another Identity not Listed
Man
Woman
Gender Fluid
Genderqueer
Gender non-conforming
Sexual Orientation

134 (39.2)
42 (12.3)
33 (9.6)
32 (9.4)
23 (6.7)
23 (6.7)
22 (6.4)
21 (6.1)
12 (3.5)
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Bisexual
Pansexual
Gay
Asexual
Another identity not listed
Heterosexual
Race or Ethnicity

114 (33.3)
78 (22.8)
61 (17.8)
45 (13.2)
29 (8.5)
15 (4.4)

Non-Hispanic White
Multiracial/ethnic
Asian/Asian American
Hispanic/Latinx
Black
Native American
Other race/ethnicity
Education Attainment

235 (68.7)
48 (14.0)
21 (6.1)
20 (5.8)
15 (4.4)
2 (.6)
1 (.3)

Middle School
GED
High School
Vocational School
Associates Degree
Bachelor’s Degree
Graduate Degree
Employment Status

2 (.6)
22 (6.4)
147 (43.0)
5 (1.5)
52 (15.2)
89 (26.0)
25 (7.3)

Unemployed
Student
Employed Part-time
Employed Full-time
Other
Receiving Disability Benefits
Retired
Annual Income

113 (33.0)
99 (28.9)
77 (22.5)
59 (17.3)
23 (6.7)
16 (4.7)
1 (.3)

$0 - $20,000
$20,001 - $40,000
$40,001 - $60,000
$60,001 - $80,000
$80,001 - $100,000
$100,000 <
Housing (Past Year)

114 (33.3)
81 (23.7)
44 (12.9)
35 (10.2)
22 (6.4)
46 (13.5)

With parents/siblings
With partner

138 (40.4)
82 (24)
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With friends/roommates
University Housing
Alone in non-university housing
Another housing/living arrangement not
listed
In a shelter or experiencing housing
instability
Health Insurance Coverage

54 (15.8)
31 (9.1)
22 (6.4)
11 (3.2)
4 (1.2)

Yes
No
Health Insurance Coverage Type

276 (80.7)
66 (19.3)

Private Insurance
Public Insurance
Limitations in Daily Activities

186 (67.4)
90 (32.6)

Yes
No
Don’t Know
Disability/Neurodivergent Identity

224 (65.5)
88 (25.7)
30 (8.8)

Yes
No
Assistive Equipment Usage

180 (52.6)
162 (47.4)

Yes
No
Don’t Know

33 (9.6)
302 (88.3)
7 (2)

Measures
Demographics
Most demographic variables (U.S. state of residence, natal sex, gender identity, sexual
orientation, race or ethnicity, education, employment status, annual income, and housing status)
were categorical. Participants were asked to type their age in a designated space. State of
Residence was assessed by asking participants to select the state they lived in at the time of
survey completion from a drop-down menu. Assigned natal sex was measured with a question
asking participants to report their sex identified at birth; participants could choose male or
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female. Gender identity data were collected by asking participants to select all gender identity
categories that applied to them. Gender identity categories included man, woman, trans man,
trans woman, non-binary, genderqueer, gender non-conforming, gender fluid, and another
identity not listed (participants were prompted to write their gender identity in a text box if they
reported that their gender identity was not listed). Sexual Orientation was measured by asking
participants to report the sexual orientation category that best described them; the categories
included Heterosexual/Straight, Homosexual/Gay, Bisexual, Pansexual, Asexual, and another
identity not listed (participants were prompted to write their sexual orientation in a text box when
they reported that their sexual orientation was not listed). Race or Ethnicity data were collected
by asking participants to select all race/ethnicity categories that applied to them. The Race or
Ethnicity categories included White, Hispanic/Latino/a, Asian/Asian American, Black/African
American, Native American, and another identity not listed (participants were prompted to write
their race/ethnicity in a text box if they reported that their race/ethnicity was not included in
response choices). A mutually exclusive race/ethnicity variable was created for data analysis
purposes, consistent with previous research analyses (Kattari et al., 2019). Education Attainment
was assessed by asking participants to indicate their highest level of formal education. Response
choices for levels of education were: middle school, high school, GED, vocational school,
associate’s degree, bachelor’s degree, and graduate degree. Employment Status data was assessed
by asking participants to select one the following categories: employed full-time, employed parttime, student, retired, on disability, unemployed, or other employment category not listed
(participants were prompted to type in their status of employment if it was not listed). Annual
Income was assessed by asking participants to indicate their household annual income by
selecting one of six categories: $0-$20,000, $20,001-$40,000, $40,001-$60,000, $60,001-
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$80,000, $80,001-$100,000, and more than $100,000. Housing Status was assessed by asking
participants to indicate where they have primarily lived since the start of the coronavirus by
choosing one of the following responses: university housing, alone or in non-university housing,
with my partner, with friends/roommates, with my parents or siblings, in a shelter or
experiencing housing instability, or another housing/living arrangement not listed. Health
Insurance Coverage was measured by asking participants if they had health insurance at the time
that the survey was being completed by selecting yes or no. Health Insurance Coverage Type
data were assessed by asking participants who indicated that they have health insurance coverage
what type (public or private) of health insurance they have. Participants were provided with
definitions for public and private insurance in an effort to support participants’ abilities to
distinguish between the two types of health care coverage. Disability/Neurodivergent Identity
data were collected by asking participants indicate whether or not they identify as disabled
and/or neurodivergent. Limitations in Daily Activities were measured by asking participants if
any of their daily activities are limited in any way because of their physical, mental, or emotional
health. Responses regarding physical limitation included: yes, no, or don’t know. Assistive
Equipment Usage was measured by asking participants if they use any assistive equipment or
technologies, such as a mobility device, a wheelchair, a special bed, screen reader, or captioning
software. Participants indicated whether they used assistive equipment by choosing from three
response choices: yes, no, or don’t know.
Healthcare Discrimination
A total of six items were adapted from the healthcare experiences portion of the 2015
U.S. Transgender Survey (James et al., 2016) to assess experiences of healthcare discrimination.
Items assessed participants’ experiences with varied types of discrimination in healthcare
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settings and when engaging with healthcare providers including: having to educate a doctor or
healthcare provider about transgender and/or gender independent people in order to receive
appropriate care, being denied transgender and/or gender independent care or general health care,
being asked unnecessary and/or invasive questions regarding gender identity status that was
unrelated to the care being sought, and being verbally or physically harassed or abused. Two
additional items were added to assess erasure in healthcare settings. Erasure items assessed
participants’ experiences with two different forms of erasure in healthcare settings or with
healthcare providers including: denial of the use of a preferred name or pronoun, and medical
forms and documents not being inclusive of an individually held gender identity. Response
choices were adopted from Testa et al’s (2015) Gender Minority Stress and Resilience Measure
(GMSR) and included: “Never”, “Yes, Before 18”, “Yes, After 18”, and “Yes, In the Past Year”.
Participants could choose multiple response choices if they experienced a specific type of
healthcare discrimination at multiple points throughout their lives. Separate summary variables
were created for childhood healthcare discrimination, past year healthcare discrimination, and
healthcare discrimination that occurred at any point in an individual’s lifetime. For each of the
summary variables, the total number of events a participant indicated for each distinct time frame
(e.g., before age 18, past year, and lifetime) were totaled, yielding scores with a possible range of
zero to eight for each variable. This measure had adequate internal consistency (a = 0.80) in the
present sample.
Healthcare Avoidance
A total of two items were adapted from the 2015 U.S. Transgender Survey (James et al.,
2016) to assess healthcare avoidance behaviors in the past year. Three additional items were
created to assess healthcare avoidance behaviors since the start of the coronavirus pandemic and
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were modeled after the two items adapted from the 2015 U.S. Transgender Survey. Healthcare
avoidance items assessed participants healthcare avoidance behaviors in distinct time frames
(e.g., past year and since the start of the coronavirus) due to various factors (cost, anticipated
discrimination, and coronavirus exposure). The five healthcare avoidance items included: (1)
“Was there a time in the past 12 months when you needed to see a doctor but could not, because
of cost?”, (2) “Was there a time in the past 12 months when you needed to see a doctor but did
not, because you thought you would be disrespected or mistreated as a trans/gender nonconforming person?”, (3) “Since the start of the coronavirus pandemic (March 11, 2020), was
there a time when you needed to see a doctor but could not, because of cost?”, (4) “Was there a
time since the start of the coronavirus pandemic when you needed to see a doctor but did not,
because you thought you would be disrespected or mistreated as a trans/gender non-conforming
person?”, (5) “Was there a time since the start of the coronavirus pandemic, when you needed to
see a doctor but did not, because you were worried about being exposed to the coronavirus in a
healthcare setting?”. Participants could select “yes” or “no” to indicate whether or not they had
avoided healthcare in the past year and/or since the coronavirus due to anticipated healthcare
cost, anticipated discrimination, and/or fear of coronavirus exposure.
Mental Health Symptoms
A total of twelve items from the Depression (six items) and Anxiety (six items) subscales
of the Brief Symptom Inventory (BSI; Derogatis, 2001) were used to assess symptoms of
depression and anxiety that occurred over the past week. Participants were asked to rate each of
the twelve items on a 5-point Likert scale, ranging from “not at all” (0) to “extremely” (4) to
indicate their experiences over that past seven days. Separate variables for anxiety and
depression symptoms experienced over the past week were created. The items for each subscale
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were summed for a total score, yielding scores with a possible range of zero to twenty-four for
each scale. There was adequate internal consistency for both the Anxiety (a = 0.89) and
Depression (a = 0.88) subscales in the present sample.
Coronavirus Health-Related Questions
Two items were adapted from Wang et al (2020) to assess whether participants had been
diagnosed with coronavirus by a healthcare provider or if participants had experienced
coronavirus symptoms. The two coronavirus health-related questions included: (1) “Have you
been told by a healthcare provider that you had the coronavirus (covid-19)?”, and (2) “Have you
had symptoms that might have been the coronavirus (covid-19) such as fever, cough, sore throat,
difficulty breathing, or loss of smell in the past 3 months, but you weren’t tested?”. Participants
who indicated that they had not been diagnosed with coronavirus by a healthcare provider were
given the question regarding having experienced coronavirus symptoms. Participants could
choose “yes” or “no” to indicate whether or not they had been diagnosed with coronavirus or
experienced symptoms of coronavirus, but had not been tested. The complete measure can be
found in Appendix B.
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Analyses
Model Checking
Data were examined for missing responses for all variables mentioned in the analyses
herein. It should be noted that there was one participant with missing data on the first two items
of the Health Discrimination measure. With the exception of the case mentioned, data from the
full sample were available for analysis for all variables. Preliminary analyses and appropriate
regression assumption checks indicated that all normality, univariate and multivariate outlier,
linearity, homoscedasticity, and multicollinearity assumptions were met. Data analyses included
descriptive statistics, two logistic regression models, and two multiple regression models.
Hypothesis 1a -1b
A direct logistic regression analysis was performed to assess whether perceived
healthcare discrimination significantly predicts past year healthcare avoidance due to anticipated
discrimination among transgender and gender independent individuals. A hierarchical logistic
regression analysis was conducted to assess whether perceived healthcare discrimination
significantly predicts past year healthcare avoidance due to anticipated discrimination when
controlling for certain demographic factors. Demographic information including: age, race,
income, insurance coverage, and disability/neurodivergence identity status were entered into the
first step, followed by the lifetime healthcare discrimination variable in the final step of the
model in order to demonstrate that healthcare discrimination can significantly predict past year
healthcare avoidance due to anticipated discrimination above and beyond the demographic
factors included in the analysis.
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Hypothesis 2a – 2b
A direct logistic regression analysis was conducted to assess whether perceived
healthcare discrimination significantly predicts healthcare avoidance since the start of the
coronavirus pandemic due to anticipated discrimination among transgender and gender
independent individuals. A hierarchical logistic regression analysis was conducted to assess
whether perceived healthcare discrimination significantly predicts healthcare avoidance since the
start of the coronavirus pandemic due to anticipated discrimination when controlling for certain
demographic factors. Demographic information including: age, race, income, insurance
coverage, and disability/neurodivergence identity status were entered into the first step of the
model, followed by lifetime healthcare discrimination variable entered in the final step of the
model in order to demonstrate that healthcare discrimination can significantly predict healthcare
avoidance due to anticipated discrimination since the start of the coronavirus pandemic above
and beyond the demographic factors included in the analysis.
Hypothesis 3
A hierarchical multiple regression was computed to assess whether perceived healthcare
discrimination significantly predicts anxiety symptoms when controlling for certain demographic
factors among transgender and gender independent individuals. Demographic information
including age and race were entered into the first step, followed by the lifetime healthcare
discrimination variable entered into the final step of the model to demonstrate that healthcare
discrimination can significantly predict anxiety symptoms above and beyond age and race.
Hypothesis 4
A hierarchical multiple regression was computed to assess whether perceived healthcare
discrimination significantly predicts depression symptoms when controlling for certain
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demographic factors among transgender and gender independent individuals. Demographic
information including age and race were entered into the first step, followed by the lifetime
healthcare discrimination variable entered into the final step of the model to demonstrate that
healthcare discrimination can significantly predict depression symptoms above and beyond age
and race.
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Results
Healthcare Discrimination
The degree to which transgender and gender independent participants reported
experiencing discrimination in healthcare settings throughout the lifespan varied across specific
healthcare discrimination items, though the majority (78.1%) of the sample reported
experiencing at least one of the eight forms of healthcare discrimination that this study examined
in their lifetime; with an overall sample average of almost two and a half (M = 2.43) distinct
forms of healthcare discrimination being reported by participants. At least once in their lifetime,
most (64.9%) participants reported that the medical forms that a doctor or other healthcare
provider asked them to complete were not inclusive of their gender identity, 42.5% reported that
they had to teach a doctor or other healthcare provider about transgender and gender independent
identities so that they could receive the appropriate healthcare, 35.7% reported that a doctor or
other healthcare provider refused to use the pronouns or name that they requested to be used
when they were referred to, and 32.7% reported being asked unnecessary and/or invasive
questions about their transgender or gender independent status that were not related to the reason
for their visit. The participants who reported that they had not been exposed to healthcare
discrimination throughout their lifetime represented a minority proportion (21.9%) of the sample.
The complete results for the eight items of the of lifetime healthcare discrimination variable can
be found in table 2.
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Table 2: Healthcare Discrimination
Never
Occurred.

Occurred
before age
18.

Occurred
after age
18.

Occurred
within the
past year.

N = 196

N = 48

N = 111

N = 58

N = 145

57.5%

14.1%

32.6%

17.0%

42.5%

N = 268

N = 31

N = 50

N = 20

N = 73

78.6%

9.1%

14.7%

5.9%

21.4%

N = 311

N = 11

N = 22

N=9

N = 31

90.9%

3.2%

6.4%

2.6%

9.1%

N = 230

N = 34

N = 85

N = 36

N = 112

67.3%

9.9%

24.9%

10.5%

32.7%

N = 281

N = 28

N = 36

N = 19

N = 61

82.2%

8.2%

10.5%

5.6%

17.8%

N = 277

N = 23

N = 44

N = 15

N = 65

81.0%

6.7%

12.9%

4.4%

19.0%

N = 220

N = 47

N = 93

N = 46

N = 122

64.3%

13.7%

27.2%

13.5%

35.7%

Healthcare
Discrimination Items:
I had to teach a doctor or
other health care
provider about
trans/gender nonconforming people so that
I could get appropriate
care.
A doctor or other health
care provider refused to
give me trans/gender
non-conforming-related
care.
A doctor or other health
care provider refused to
give me other health care
(such as physical exam,
flu, diabetes).
A doctor asked me
unnecessary/invasive
questions about my
trans/gender nonconforming status that
were not related to the
reason for my visit.
A doctor or other health
care provider used harsh
or abusive language
when treating me.
I was verbally harassed
in a health care setting
(such as hospital, office,
clinic).
A doctor or other health
care provider refused to
use the pronouns or name
that I requested to be
used.

Occurred
at least
once in
Lifetime.
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The medical forms or
documents that a doctor
or other health care
provider asked me to
complete did not include
my gender identity.

N = 120

N = 108

N = 180

N = 127

N = 222

35.1%

31.6%

52.6%

37.1%

64.9%

Healthcare Avoidance
Reported healthcare avoidance in the past year and since the start of the coronavirus
pandemic varied across rationales for avoidance of needed healthcare (i.e., cost, anticipated
discrimination, and fear of coronavirus exposure). Avoidance of needed healthcare due to
healthcare costs in the past year was reported by just under half (46.8%) of participants, and
healthcare avoidance since the start of the coronavirus pandemic was reported by 30.1% of
participants. Over a quarter (26.3%) of participants reported avoiding needed healthcare in the
past year and 16.1% since the start of the coronavirus pandemic due to anticipated discrimination
in healthcare settings because of their transgender or gender independent identity. A third
(36.3%) of participants reported avoiding needed healthcare since the start of the coronavirus
pandemic due to fears of coronavirus exposure in a healthcare setting. The complete results for
the healthcare avoidance variable can be found in table 3.
Table 3: Healthcare Avoidance
Healthcare Avoidance Items:
Was there a time in the past 12 months
when you needed to see a doctor but
could not because of cost?
Was there a time in the past 12 months
when you needed to see a doctor but did
not because you thought you would be
disrespected or mistreated as a
trans/gender non-conforming person?
Since the start of the coronavirus
pandemic (March 11, 2020), was there a

Yes

No

N = 160

N = 182

46.8%

53.2%

N = 90

N = 252

26.3%

73.7%

N = 103

N = 239
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time when you needed to see a doctor but
could not because of cost?
Was there a time since the start of the
coronavirus pandemic when you needed
to see a doctor but did not because you
thought you would be disrespected or
mistreated as a trans/gender nonconforming person?
Was there a time since the start of the
coronavirus pandemic, when you needed
to see a doctor but did not because you
were worried about being exposed to the
coronavirus in a health care setting?

30.1%

69.9%

N = 55

N = 287

16.1%

83.9%

N = 124

N = 218

36.3%

63.7%

Mental Health Symptoms
Predominately, the sample reported moderately high levels of depressive (M = 10.85, SD
= 5.97) and anxiety symptoms (M = 8.97, SD = 5.65) based on their scores on the BSI depression
and anxiety subscales (Derogatis, 2001). The majority (73%) of participants scored at or above
the clinical threshold on the depression subscale. Over half (62%) of participants scored at or
above the clinical threshold (³7) on the anxiety subscale.
Coronavirus Health-Related Questions
The majority (99.1%) of the sample reported that they had not been diagnosed with the
coronavirus by a healthcare provider, while .9% (n = 3) participants reported having been told by
a healthcare provider that they had the coronavirus. A fourth (25.4%) of the participants (n =
339) who reported that they had not been diagnosed with the coronavirus reported that they had
experienced symptoms that might have been the coronavirus in the three months prior to
participating in the study (e.g., fever, cough, sore throat, difficulty breathing, or loss of smell),
but had not been tested for the coronavirus. The majority (74.6%) of participants who reported
that they had not been diagnosed with the coronavirus reported that they had not experienced
symptoms that might have been the coronavirus.
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Hypothesis 1a-1b: Past Year Healthcare Avoidance Analyses
A direct logistic regression analysis was conducted to assess whether perceived
healthcare discrimination significantly predicted past year healthcare avoidance due to
anticipated discrimination among the transgender and gender independent sample. A test of the
full model against a constant only model was significant, c2(1, N = 342) = 54.69, p < .001,
Nagelkerke R2 = .22; indicating that healthcare discrimination as a sole predictor reliably
distinguished between participants who did and did not avoid healthcare in the past year.
According to Wald’s criterion, healthcare discrimination was further affirmed as a significant
predictor of past year healthcare avoidance due to anticipated discrimination, c2(1) = 46.67, p <
.001. The change in odds associated with a one-unit change in score on the healthcare
discrimination measure was 1.52 (95% CI = 1.35-1.71), indicating that higher exposure to
healthcare discrimination was associated with a 52% increase in the likelihood of past year
healthcare avoidance.
A hierarchical logistic regression analysis (see table 4) was conducted to assess whether
perceived healthcare discrimination significantly predicted past year healthcare avoidance due to
anticipated discrimination when controlling for five demographic factors. Demographic
information including: age, race, income, insurance coverage, and disability/neurodivergence
identity status were entered into the first step of the model, followed by the lifetime healthcare
discrimination variable entered in the final step of the model. When the five demographic
variables were entered into the model and tested against the constant only model, they
significantly predicted past year healthcare avoidance, χ2 (5) = 13.39 p = .02, Nagelkerke R2 =
.056, accounting for 5.6% of the variance. At the initial step of the model,
disability/neurodivergence identity status was a significant independent predictor of past year
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healthcare avoidance χ2 (1) = 8.46, p = .004, OR = 2.13, 95% CI [1.28-3.54]. When the
healthcare discrimination variable was entered into the model a test of the full model against the
constant only model significantly improved prediction of past year healthcare avoidance, χ2 (6) =
65.01, p < .001, Nagelkerke R2 = .25, indicating that together age, race, income, insurance
coverage, disability/neurodivergent identity status, and healthcare discrimination reliably
distinguished between those who did or did not avoid needed healthcare in the past year,
accounting for 25% of the variance. Healthcare discrimination, χ2 (1) = 44.14, p < .001, OR =
1.54, 95% CI [1.35-1.75], p < .001, significantly predicted healthcare avoidance in the past year
over and above the five demographic variables. For each one point increase in healthcare
discrimination exposure, participants were 54% more likely to avoid needed healthcare in the
past year due to anticipating discrimination.
Table 4: Past Year Healthcare Avoidance
Variable & Step

OR

CI

B

S.E.

p

Age

.97

(.93-1.00)

-.034

.019

ns

Race

.83

(.48-1.42)

-.188

.276

ns

Income

.92

(.79-1.06)

-.082

.075

ns

Health Insurance

1.46

(.76-2.81)

.377

.335

ns

Disability

2.13

(1.28-3.54)

.756

.260

.004

1.54

(1.35-1.75)

.430

.065

<.001

Step 1:

Step 2:
Healthcare Discrimination
N = 342, ns = not significant
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Hypothesis 2a-2b: Healthcare Avoidance Since the Start of the Coronavirus Analyses
A direct logistic regression analysis was conducted to assess whether perceived
healthcare discrimination significantly predicted healthcare avoidance since the start of the
coronavirus pandemic due to anticipated discrimination. A test of the full model against a
constant only model was significant, c2(1, N = 342) = 46.73, p < .001, Nagelkerke R2 = .22;
indicating that healthcare discrimination as a sole predictor reliably distinguished between
participants who did and did not avoid needed healthcare since the start of the coronavirus
pandemic due to anticipated discrimination. According to Wald’s criterion, healthcare
discrimination was further affirmed as a significant predictor of healthcare avoidance since the
start of the coronavirus pandemic due to anticipated discrimination, c2(1) = 41.14, p < .001. The
change in odds associated with a one-unit change in score on the healthcare discrimination
measure was 1.55, 95% CI = [1.36-1.78], indicating that higher exposure to healthcare
discrimination increased the likelihood of healthcare avoidance since the start of the coronavirus
pandemic by 55%.
A hierarchical logistic regression analysis (see table 5) was conducted to assess whether
perceived healthcare discrimination significantly predicted healthcare avoidance since the start of
the coronavirus pandemic due to anticipated discrimination when controlling for five
demographic factors. Demographic information including: age, race, income, insurance
coverage, and disability/neurodivergence identity status were entered into the first step of the
model, followed by the lifetime healthcare discrimination variable entered in the final step of the
model. When the five demographic variables were entered into the model and tested against the
constant only model, they significantly predicted healthcare avoidance since the start of the
coronavirus, χ2 (5) = 14.98, p = .01 Nagelkerke R2 = .07. At the initial step of the model
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disability/neurodivergent identity χ2 (1) = 9.58, p < .002, OR = 2.77, 95% CI [1.45-5.28] was a
significant individual predictor of healthcare avoidance since the start of the coronavirus
pandemic. When the healthcare discrimination variable was entered into the model a test of the
full model against the constant only model significantly improved prediction of healthcare
avoidance since the start of the coronavirus pandemic, χ2 (6) = 55.68, p < .001, Nagelkerke R2 =
.26, indicating that together age, race, income, insurance coverage, disability/neurodivergent
status, and healthcare discrimination reliably distinguished between those who did or did not
avoid needed healthcare since the start of the coronavirus pandemic, accounting for 26% of the
variance (accounting for 19% more in variance than the first step of the model). Healthcare
discrimination, χ2 (1) = 36.27, p < .001, OR = 1.55, 95% CI [1.34-1.78], p < .001, significantly
predicted healthcare avoidance since the start of the coronavirus pandemic over and above the
five demographic variables. For each one point increase on the healthcare discrimination
measure, participants were 55% more likely to avoid needed healthcare since the start of the
coronavirus pandemic. Having a disability/neurodivergent identity χ2 (1) = 3.90, p = .048, OR =
2.01, 95% CI [1.01-4.04] decreased in its significance as an independent predictor of healthcare
avoidance since the start of the coronavirus pandemic due to anticipated healthcare
discrimination at this step.
Table 5: Healthcare Avoidance Since Start of the Coronavirus
Variable & Step

OR

CI

B

S.E.

p

Age

.98

(.93-1.02)

-.024

.023

ns

Race

.88

(.46-1.70)

-.125

.333

ns

Income

.85

(.70-1.02)

-.164

.096

ns

Step 1:
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Health Insurance

1.35

(.63-2.93)

.303

.393

ns

Disability

2.77

(1.45-5.29)

1.020

.329

.002

1.55

(1.34-1.78)

.435

.072

<.001

Step 2:
Health Discrimination
N = 342, ns = not significant
Hypothesis 3: Anxiety Symptoms Analysis
A hierarchical multiple linear regression analysis (see table 6) was conducted to assess
whether perceived healthcare discrimination significantly predicted anxiety symptoms when
controlling for two demographic factors. Demographic information including age and race were
entered into the first step of the model, followed by lifetime healthcare discrimination entered in
the final step of the model. When age and race were entered into the model, they significantly
predicted anxiety symptoms, F(2, 339) = 5.34 p = .005, R2 = .031. This initial model shows that
only 3.1% of reported anxiety symptoms could be predicted by knowing a participant’s age or
race. Older participants reported fewer anxiety symptoms, compared with younger participants.
Compared to Non-Hispanic white participants, People of Color scored 1.28 points lower, on
average, in anxiety symptoms than Non-Hispanic whites. When the healthcare discrimination
variable was added to the model, it significantly improved the prediction of anxiety symptoms
over and above the two demographic variables, ∆R2 = .084, ∆F(1, 338) = 32.17, p < .001. All
variables together significantly predicted anxiety symptoms, F(3, 338) = 14.61, p < .001, R2 =
.115. The final model shows that 11.5% of the variance in reported anxiety symptoms could be
predicted by knowing an individual’s age, race, and lifetime healthcare discrimination exposure.
Healthcare discrimination (B = .745, t(338) = 5.67, p < .001) significantly predicted anxiety

45
symptoms over and above age and race. For every one unit change on the healthcare
discrimination measure, a participants depression score increased by .75.
Table 6: Anxiety Symptoms
Variable & Step

R2

R2 Change

.031

.031**

B

S.E

t

Age

-.123

.042

-2.90**

Race

-1.276

.658

-1.94*

.745

.131

5.67***

Step 1:

Step 2:

.115

Healthcare Discrimination

.084***

N = 342, *p <.05; **p <.01; ***p < .001
Hypothesis 4: Depressive Symptoms Analysis
A hierarchical multiple regression analysis (see table 7) was conducted to assess whether
perceived healthcare discrimination significantly predicted depressive symptoms when
controlling for two demographic factors. Demographic information including age and race were
entered into the first step of the model, followed by the lifetime healthcare discrimination entered
in the final step of the model. When age and race were entered into the model, they significantly
predicted depressive symptoms, F(2, 339) = 6.91, p = .001, R2 = .039. This initial model shows
that only 3.9% in reported depressive symptoms could be predicted by knowing a participant’s
age or race. Older participants reported fewer depressive symptoms, compared with younger
participants. Compared to Non-Hispanic white participants, People of Color scored .30 points
lower, on average, in depressive symptoms than Non-Hispanic whites. When the healthcare
discrimination variable was added to the model, it significantly improved the prediction of
depressive symptoms over and above the two demographic variables, ∆R2 = .044, ∆F(1, 338) =
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16.09, p < .001. All variables together significantly predicted depressive symptoms, F(3, 338) =
10.17, p < .001, R2 = .083. The final model shows that 8.3% of the variance in reported
depressive symptoms could be predicted by knowing an individual’s age, race, and lifetime
healthcare discrimination exposure. Healthcare discrimination (B = .567, t(338) = 4.01, p < .001)
significantly predicted depressive symptoms over and above age and race. For every one unit
change on the healthcare discrimination measure, a participants depression score increased by
.57. In this step of the model, age (B = .-.185, t(338) = -4.21, p < .001) was a significant
individual predictor of depressive symptoms, while race (B= -.486, t(338) = -.714, p = .475) was
not a significant individual predictor.
Table 7: Depressive Symptoms
Variable & Step

R2

R2 Change

.039

.039**

B

S.E.

t

Age

-.166

.045

-3.71***

Race

-.301

.693

-.44

.567

.141

4.01***

Step 1:

Step 2:

.083

Healthcare Discrimination

.044***

N = 342, , *p <.05; **p <.01; ***p < .001
Exploratory Analyses: The potentiality of Disability/Neurodivergent Status as a Moderator
An exploratory hierarchical logistic regression moderation analysis was conducted to
evaluate the influence of disability/neurodivergent status on the relationship between perceived
healthcare discrimination and past year healthcare avoidance due to anticipated discrimination.
Prior to analyses, the independent (healthcare discrimination) and moderation
(disability/neurodivergent status) variables were centered and a product term was created as
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recommended by Baron & Kenny (1986). Perceived healthcare discrimination significantly
predicted past year healthcare avoidance due to anticipated discrimination, χ2 (1) = 42.85, p <
.001, OR = 1.51, 95% CI [1.33-1.71]. Disability/neurodivergent identity status, χ2 (1) = 2.96, p =
.085, OR = 1.65, 95% CI [.93-2.92] did not significantly predict past year healthcare avoidance
due to anticipated discrimination. The association between perceived healthcare discrimination
and past year healthcare avoidance due to anticipated discrimination was not moderated by
disability/neurodivergent status, χ2 (1) = .86, p = .353, OR = .89, 95% CI [.69-1.14].
An exploratory hierarchical logistic regression moderation analysis was conducted to
evaluate the influence of disability/neurodivergent status on the relationship between perceived
healthcare discrimination and healthcare avoidance since the start of the coronavirus pandemic
due to anticipated discrimination. Prior to analyses, the independent (healthcare discrimination)
and moderation (disability/neurodivergent status) variables were centered and a product term
was created as recommended by Baron & Kenny (1986). Perceived healthcare discrimination, χ2
(1) = 35.36, p < .001, OR = 1.53, 95% CI [1.33-1.76] and disability/neurodivergent identity
status, χ2 (1) = 3.95, p = .047, OR = 2.19, 95% CI [1.01-4.73] significantly predicted healthcare
avoidance since the start of the coronavirus pandemic due to anticipated discrimination. The
association between perceived healthcare discrimination and healthcare avoidance since the start
of the coronavirus pandemic due to anticipated discrimination was not moderated by
disability/neurodivergent status, χ2 (1) = .02, p = .900, OR = .98, 95% CI [.74-1.30].
Discussion
The aim of this study was to evaluate the relationship between lifetime exposure to varied
forms of healthcare discrimination and four variables: (1) healthcare avoidance behaviors in the
past year due to anticipated discrimination, (2) healthcare avoidance behaviors since the start of
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the coronavirus pandemic due to anticipated discrimination, (3) anxiety symptoms, and (4)
depressive symptoms in a transgender and gender independent sample. Consistent with prior
research that has conveyed prevalence estimates of the barriers that exist for the transgender and
gender independent population in accessing healthcare, (Grant et al., 2011; James et al., 2016;
Macapagal et al., 2016; Rodriguez et al., 2017; Shires & Jaffee, 2015) the results of this study
make apparent the pervasiveness of exposure to healthcare discrimination and convey its
deleterious relationship with psychological health and healthcare engagement behaviors in this
population. The majority (78.1%) of participants reported experiencing at least one of the eight
forms of healthcare discrimination that this study examined in their lifetime.
The results of this study reveal the lifetime exposure to various forms of discrimination in
healthcare settings that is endemic to the transgender and gender independent individual’s
experience. Specifically, this study provides evidence of the direct (e.g., refusal of care) and
indirect (e.g., non-inclusive medical forms and/or unnecessary and invasive questions) forms of
healthcare discrimination that this population is exposed to. Exposure to healthcare
discrimination might diminish the trust in healthcare institutions and providers that may be
imperative to patient engagement in care (e.g., preventative care), patient trust in provider
recommendations (e.g., vaccinations), and improving patient health outcomes (e.g., disease
management). To seek or require healthcare involves psychological and physical vulnerability,
as individuals seek care when they are incapable of providing care for themselves. Although
individuals seek healthcare for a myriad of reasons (e.g., illness prevention, disease management,
physical trauma and injury, psychological support, etc.), common reasons why individuals might
seek or require healthcare are solace and healing.
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The results of this study provide evidence of transgender and gender independent patients
experiences in healthcare settings that may have the potential to be physically and
psychologically harmful. This is evident in the participants’ reporting of medical forms not being
inclusive of their gender identity (64.9%) at least once in their lifetime. Medical forms are often
the first form of communication that a patient is given to convey their identities, past illnesses,
diagnoses, health behaviors, etc. If a patient’s gender identity is not included on medical forms,
this may potentially result in a patient’s negative appraisal of their belongingness in healthcare
settings. The exclusion of transgender and gender independent individuals’ identities on medical
forms and records may be associated with the lack of knowledge that healthcare providers have
about these patients, their intersecting identities, and their health behaviors. This may explain
why 42.5% of the participants reported having to teach a healthcare provider about transgender
and gender independent people in order to receive appropriate care at least once in their lifetime.
Although participants who reported harsh or abusive language (17.8%) being used by a
healthcare provider, and/or that they were harassed in a healthcare setting (19%) represented the
minority of the sample, this form of discrimination would be considered to be profoundly
harmful to encounter in any setting – but especially in a healthcare setting. In addition to
engagement in healthcare avoidance behaviors, transgender and gender independent individuals
may conceal their gender identities to avoid the discrimination they anticipate encountering in
healthcare settings, which has healthcare accessibility (e.g., STI testing, gender affirming care,
etc.) and outcome (e.g., receiving inappropriate care) implications (Bauer et al., 2009; Cruz,
2014).
The results of this study substantiate Hypothesis 1a-1b, which predicted that perceived
healthcare discrimination would significantly predict past year healthcare avoidance due to
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anticipated discrimination after accounting for other factors that might impact healthcare
avoidance behaviors (e.g., age, race/ethnicity, income, disability/neurodivergent status, and
health insurance coverage). More concretely, independent of an individual’s age, race/ethnicity,
income level, disability/neurodivergent identity, and/or whether or not they have health
insurance coverage, their lifetime exposure to healthcare discrimination predicted avoiding
needed healthcare in the past year when they anticipated encountering gender identity-based
discrimination. Findings indicate that higher levels of lifetime exposure to varied forms of
healthcare discrimination significantly increases the likelihood that transgender and gender
independent individuals will avoid needed healthcare due to anticipation of gender identity-based
discrimination in healthcare settings. Although the prevalence of exposure to healthcare
discrimination and its relationship to healthcare avoidance behaviors have been well documented
(Bauer et al., 2014; Bauer et al., 2015; Bradford et al., 2013; Jaffee et al., 2016; Macapagal et al.,
2016; Seelman et al., 2017), these results empirically advance the knowledge about the harmful
impacts that exposure to healthcare discrimination has on this population. This study evaluated
healthcare avoidance behaviors due to anticipation of discrimination based on eight forms of
healthcare discrimination encountered at least once in the lifetime of participants. This
knowledge makes apparent the considerable toll that healthcare discrimination has on
transgender and gender independent individuals in instances when they must consider the
potential risks of seeking or avoiding varied forms of healthcare beyond gender affirming care
(e.g., preventative, chronic disease management, gynecological and reproductive, etc.) when it is
needed. Healthcare avoidance behaviors have been found to have adverse impacts on the
physical and psychological health of transgender and gender independent individuals (Seelman
et al., 2017). Individuals who delay or avoid seeking healthcare may experience health disparities
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that contribute to morbidity and mortality. In particular, associations between delaying needed
healthcare and delays in cancer diagnosis (Céspedes et al., 2020; Langlands et al., 2002), cancer
prognosis (Zhang et al., 2015), and early mortality in cancer patients (Biagi et al, 2011; Hanna et
al., 2020; Raphael et al., 2016) have been documented. The disparities in rates of morbidities and
disabilities reported by transgender and gender independent individuals compared to cisgender
individuals (Fredriksen-Goldsen et al., 2014; Witten, 2014) may be related to health avoidance
behaviors and/or the discrimination they are exposed to in healthcare settings.
The results of this study support Hypothesis 2a-2b, which predicted that perceived
healthcare discrimination would significantly predict healthcare avoidance behaviors since the
start of the coronavirus due to anticipated discrimination after accounting for other factors that
might impact healthcare avoidance behaviors (e.g., age, race/ethnicity, income,
disability/neurodivergent status, and health insurance coverage). More explicitly, independent of
an individual’s age, race/ethnicity, income level, disability/neurodivergent identity, and/or
whether or not they have health insurance coverage, their lifetime exposure to healthcare
discrimination predicted avoiding needed healthcare since the start of the coronavirus when they
anticipated encountering discrimination based on their gender identity. The results of the
analyses performed to test this hypothesis indicate that higher levels of lifetime exposure to
varied forms of healthcare discrimination are significantly associated with an increase in the
likelihood that transgender and gender independent individuals will avoid needed healthcare
even during a global pandemic due to anticipation of gender identity-based discrimination in
healthcare settings. As previously noted, prior research has documented the prevalence of
exposure to healthcare discrimination and its relationship to healthcare avoidance behaviors;
these results empirically advance the knowledge about the harmful impacts that lifetime
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exposure to healthcare discrimination has on this population by evaluating the healthcare
avoidance behaviors since the start of the coronavirus due to anticipation of discrimination based
on the culmination of varied forms of healthcare discrimination. This knowledge demonstrates
that discriminatory encounters in healthcare settings in addition to the anticipation for similar
encounters is associated with transgender and gender independent patients’ appraisal of their
access to varied types of care including being tested and/or treated for the coronavirus when
symptoms are present, or when they have been exposed to someone who has tested positive for
the coronavirus. Healthcare avoidance is predominately viewed as a behavior that involves risk
at an individual level, but avoiding needed healthcare (e.g., being tested and/or treated for the
coronavirus, getting a vaccine in an attempt to mitigate the spread of the coronavirus, etc.)
presents a public health concern during a global pandemic.
The results of this study substantiate Hypotheses 3 and 4, which predicted that perceived
healthcare discrimination would be significantly associated with anxiety and depressive
symptoms after accounting for other factors that might predict anxiety symptoms including age
and race/ethnicity. More explicitly, independent of an individual’s age and/or race/ethnicity, their
lifetime exposure to healthcare discrimination is a stronger predictor of their anxiety and
depressive symptoms. These results indicate that higher levels of lifetime exposure to varied
forms of healthcare discrimination is significantly associated with an increase in anxiety and
depressive symptoms in transgender and gender independent individuals. Although previous
research has articulated the elevated levels of psychological distress reported by this population
related to discrimination (Barzagan & Galvin, 2012; Bockting et al.., 2013; Clements‐Nolle et
al., 2006; Dispenza et al., 2012; James et al., 2016; Rotondi et al., 2011; Staples et al., 2018;
Tebbe & Moradi, 2016; Testa et al., 2017, 2015), these results empirically advance the
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knowledge about the harmful relationship between lifetime exposure to varied forms of
healthcare discrimination and this population’s psychological health.
Implications for Clinical Practice
These findings have significant implications for clinical practice. The centrality of
healthcare discrimination in transgender and gender independent individuals’ healthcare
avoidance behaviors, elevated rates of disabilities, morbidities, and psychological distress can be
nullified. Healthcare discrimination is not only a malleable barrier to this population’s access to
healthcare and/or the quality of the care they are able to receive, it also contradicts the ethical
principles that healthcare professionals subscribe to. The American Medical Association (AMA;
2016) has adopted nine “Principles of Medical Ethics” that serve to be standards of honorable
conduct for healthcare professionals. The AMA’s (2016) principles hold that healthcare
professionals have an ethical imperative not limited to seeking advancements in science and
medical education, but also to providing access to competent medical care that is encompassing
of human dignity to “all people”. Although, healthcare professionals are obligated to follow
laws, they are also encouraged to “recognize a responsibility to seek changes in those
requirements which are contrary to the best interests of the patient” (AMA, 2016). Healthcare
providers who engage and/or are complicit in the eight forms of direct or indirect healthcare
discrimination that this study evaluated are in direct violation of such principles.
The adoption of several healthcare initiatives aiming to improve healthcare accessibility
for transgender and gender independent individuals may serve to mitigate the harmful impacts
associated with the insidious messages that convey disregard for the health of these individuals.
Healthcare institutions and providers can ensure that the barriers of transphobia and
cisnormativity are replaced with a conceptualization of gender as a nonbinary construct. It is
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imperative that healthcare providers attend to their individual appraisals and biases about gender
identity and expression, as such biases and appraisal may impact the quality of care they provide
to transgender and gender independent patients. Healthcare institutions have an obligation to
ensure that whether or not providers value cultural humility (Patallo, 2019), that any knowledge
deficits related to the healthcare needs of transgender and gender independent patients are
attended to. Healthcare institutions can ensure that the entirety of healthcare teams (e.g., intake
staff, billing staff, and providers) are provided with the training and educational materials
necessary to provide quality care for and promote respectful dialogue with this population about
their healthcare needs. Transgender and gender independent patients are not obligated nor should
they be burdened with providing education to their healthcare providers in order to have their
healthcare needs be met.
It is critical that healthcare institutions utilize inclusive documentation methods (i.e.,
intake forms and electronic health records). The use of inclusive intake forms and electronic
records would allow patients to disclosure their gender identity and/or the manner in which their
gender identity intersects with their bodies, for clear documentation and dissemination to their
healthcare teams. Health providers should be aware of and attend to the preferred names, gender
identity terms, and pronouns (e.g., zir, ze, Mx, he, she, xe, they) that transgender and gender
independent patients regard as most representative of their identities.
The health status and/or concerns of transgender and gender independent patients may be
amalgamated by multiple points of their intersecting identities and may or may not be linearly
associated with their gender identity. All healthcare institutions, including university and
community health clinics that provide gender affirming healthcare services (e.g., prescribing
and/or managing hormone replacement therapies) to transgender and gender independent patients
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must not neglect the other healthcare needs of these patients. Engaging transgender and gender
independent patients in a manner that encompasses integrated healthcare services may be
supportive of an increase in their healthcare utilization and better health outcomes as seen in
other patient populations (Martin et al., 2014).
Affordability must also be considered when attempting to address accessibility disparities
in healthcare faced by this population. Healthcare institutions must not neglect the healthcare
needs of uninsured or underinsured transgender and gender independent patients, and consider
their vulnerability to employment and healthcare insurance discrimination. The implementation
of confidential processes by which transgender and independent patients can report their
healthcare experiences is an important step in healthcare institutions accepting the obligation to
ensure that healthcare is accessible to these patients. It is imperative that this population’s
healthcare experiences are captured, including those experiences that may be facilitative of
healthcare utilization and avoidance to inform prevention and intervention methods.
Collaborative and coordinated action within and outside of healthcare institutions is required to
ameliorate the healthcare accessibility barriers (e.g., economic inequities, discrimination, and
erasure) that are extraordinarily onerous for the transgender and gender independent population.
Implication for Policy
Individual, societal, and institutional bias, stigma, and discrimination persist due to the
existence of policies that restrict transgender and gender independent individuals’ rights,
including their right to access healthcare. The findings of this study provide evidence for the
imperativeness of legislating healthcare policy protections and repealing the policies that
sanction the erasure and discrimination that transgender and gender independent individuals are
exposed to in healthcare settings. The U.S. Supreme Court recently ruled that employers cannot
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fire transgender and gender independent individuals based on their gender identity (U.S. Equal
Opportunity Commission, 2020). Still, this population remains vulnerable to local, state, and
federal legislative and regulatory aggressions that further stigmatize, criminalize, delegitimize,
and dehumanize the embodiment of a transgender and gender independent identity.
According to the American Civil Liberties Union (ACLU; 2021), dozens of states will
introduce legislation seeking to prohibit and restrict rights and protections for transgender and
gender independent citizens before the end of 2021. Legislatures are also seeking to advance
religious rights and protections for individuals, schools, and healthcare institutions to be
discriminatory based on gender identity (ACLU, 2021). These religious exemption bills have the
potential to exacerbate the harmful impacts of the healthcare avoidance behaviors exhibited by
this population, as Catholic and other religious healthcare institutions are prominent in U.S.
healthcare.
This study makes clear the prevalence of denial of gender affirming care at varying
developmental stages, with 21.4% of the participants reporting that they experienced this form of
healthcare discrimination at least once in their lifetime, and 9.1% reporting that they had been
denied gender affirming care before age 18. These findings are consistent with the current
proposals of legislation being advanced and/or passed to prohibit healthcare for transgender and
gender independent youth (ACLU, 2021). The Alabama Senate recently passed the “Vulnerable
Child Compassion and Protection Act” (i.e., Alabama Senate Bill 10), which would prohibit
transgender and gender independent youth from receiving gender affirming care if passed by the
Alabama House of Representatives committee on Health and signed by the governor – Kay Ivey
(ACLU, 2021).

57
Policies that make explicit the illegality of healthcare discrimination in all of its forms
(including denial of care) must be enacted to ensure that this population is not physically or
psychologically harmed further by the inaccessibility and underutilization of healthcare
associated with discrimination and erasure. This study provides evidence of the informational
and institutional erasure that transgender and gender independent healthcare consumers are
exposed to, as 64.9% of this sample reported that medical intake forms were not inclusive of
their gender identities. Robust policy must be enacted to require local, state, and federal
healthcare institutions and organizations to capture the intersecting identities of transgender and
gender independent healthcare consumers, and to respond to their healthcare needs. Healthcare
institutions and organizations whose research and operations are partially or fully funded by
public funds should be obligated to identify health risks, outcomes, and disparities associated
with transgender and gender independent constituents. The deficit of local, state, and federal
policy protections regarding transgender and gender independent healthcare provides a gateway
for proposed legislation to be distinctly reflective of the healthcare needs of the transgender and
gender independent community.
Limitations and Implication for Future Research
While this study may elucidate the chronicity of the indiscriminate forms of lifetime
healthcare discrimination experienced by this population and its harmful associations with
healthcare avoidance behaviors and psychological distress, there were limitations that must be
considered. This study utilized a cross-sectional survey design, which did not allow for causal
inferences. Longitudinal cohort studies should be employed to expand knowledge regarding: (a)
transgender and gender independent identity development and healthcare accessibility barriers,
and/or facilitators; (b) relationships that might exist between facilitators and/or barriers to
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healthcare accessibility and health behaviors, and outcomes across varied developmental stages.
This study used an online and non-probability sampling method, thereby lessoning its
representativeness of the diversity that exists among the transgender and gender independent
population, despite its geographical representativeness of the U.S; the most marginalized tier
(e.g., those who are most economically vulnerable) of this population were unable to be
accessed. However, this study was able to capture the experiences of transgender and
independent individuals in a manner that sought to minimize the potential coronavirus exposure
and potential anxiety symptoms experienced by participants that might be associated with fear of
further stigmatization and discrimination associated with their gender identity status. Future
studies should strive to utilize probability sampling to support: (a) generalizability of the results
to the full spectrum of identities held within this population; (b) exploration of other social
identity factors that may contribute to healthcare accessibility, avoidance, and outcomes in this
population. While this study was able to capture the prevalence of healthcare discrimination and
healthcare avoidance behaviors associated with the discrimination faced in healthcare settings by
this population, it did not investigate discriminatory experiences with and avoidance of distinct
types of healthcare settings/providers (e.g., gynecology, oncology, endocrinology, psychology).
Future studies should engage transgender and gender independent individuals in quantitative and
qualitative inquiries about their exposure to and avoidance of distinct forms of erasure and
discrimination within specific divisions of healthcare. This study garnered information about
participants intersecting identities with disabilities/neurodivergence and found it to be a predictor
of healthcare avoidance, but did not inquire about participant diagnoses of specific chronic
mental and/or physical health conditions. Future research should evaluate distinct health
conditions as potential moderators of the relationship between healthcare discrimination and
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utilization in this population. Healthcare discrimination was found to be a significant predictor of
anxiety symptoms among this sample. However, this study did not investigate the potentiality for
an association between anxiety with healthcare avoidance behaviors and/or distrust in healthcare
institutions in this population. Knowledge about the varying facilitators and/or barriers to
utilization or underutilization of healthcare would be supportive of future research encompassing
controlled trial experiments regarding the efficacy of healthcare interventions to address the poor
healthcare outcomes seen in this population.
Conclusion
Notwithstanding these limitations, this study provides information that is critical to
understanding the health behaviors and subsequent health implications for the transgender and
gender independent population. This study provides evidence of the persistence of myriad
institutional, structural, and ideological barriers to this population’s ability to access healthcare
with associations of deleterious health behaviors (e.g., avoidance) generally and amidst a global
pandemic, and psychological distress. This study has various applied implications for healthcare
institutions, providers, researchers, legislators, and LGBTQ+ community organizations in the
advancement of targeted intervention strategies (e.g., institutional, clinical, and policy) to
mitigate health disparities in this population. Future research directions should include further
exploration into the specific barriers (e.g., erasure themes) and facilitators (e.g., access to
integrated healthcare) of healthcare utilization at various stages throughout the transgender and
gender independent individual’s lifespan.

60
References
American Civil Liberties Union (2021, March 18). Legislation affecting lgbt rights across the
country. Retrieved March 23, 2021, from https://www.aclu.org/legislation-affecting-lgbtrights-across-country
American Medical Association. (2016). AMA principles of medical ethics. Retrieved March 17,
2021, from https://www.ama-assn.org/about/publications-newsletters/ama-principlesmedical-ethics
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental
disorders, 5th edition (DSM-5). Washington, DC: American Psychiatric Association.
American Psychological Association. (2015) Guidelines for psychological practice with
transgender and gender nonconforming people. The American Psychologist, 70(9), 832864.
Bakko, M., & Kattari, S. K. (2020). Transgender-Related Insurance Denials as Barriers to
Transgender Healthcare: Differences in Experience by Insurance Type. Journal of
General Internal Medicine : JGIM, 35(6), 1693-1700.
Bariola, E., Lyons, A., Leonard, W., Pitts, M., Badcock, P., & Couch, M. (2015). Demographic
and psychosocial factors associated with psychological distress and resilience among
transgender individuals. American Journal of Public Health., 105(10), 2108-2116.
Baron, R. M, & Kenny, D. A. (1986). The moderator-mediator variable distinction in social
psychological research. Journal of Personality and Social Psychology, 51(6), 1173-1182.

61
Barr, S. M., Budge, S. L., & Adelson, J. L. (2016). Transgender community belongingness as a
mediator between strength of transgender identity and well-being. Journal of Counseling
Psychology, 63(1), 87-97.
Bazargan, M., & Galvan, F. (2012). Perceived discrimination and depression among low‐in‐
come Latina male‐to‐female transgender women. BMC Public Health, 12, 663.
Bauer, G. R., Hammond, R., Travers, R., Kaay, M., Hohenadel, K. M., & Boyce, M. (2009). “I
don’t think this is theoretical; this is our lives”: How erasure impacts health care for
transgender people. Journal of the Association of Nurses in AIDS Care, 20(5), 348-361.
Bauer, G. R., Scheim, A. I., Deutsch, M. B., & Massarella, C. (2014). Reported emergency
department avoidance, use, and experiences of transgender persons in Ontario, Canada:
Results from a respondent-driven sampling survey. Annals of Emergency Medicine, 63(6),
713-720.
Bauer, G. R., Zong, X., Scheim, A. I., Hammond, R., & Thind, A. (2015). Factors impacting
transgender patients’ discomfort with their family physicians: A respondent-driven
sampling survey. PLoS ONE, 10(15), e0145046.
Benotsch, E. G., Zimmerman, R., Cathers, L., McNulty, S., Pierce, J., Heck, T., Perrin, P. B., &
Snipes, D. (2013). Non-medical use of prescription drugs, polysubstance use, and mental
health in transgender adults. Drug and Alcohol Dependence, 132(1-2), 391-394.
Biagi, J. J., Raphael, M. J., Mackillop, W. J., Kong, W., King, W. D., & Booth, C. M. (2011).
Association between time to initiation of adjuvant chemotherapy and survival in
colorectal cancer: A systematic review and meta-analysis. JAMA : the Journal of the
American Medical Association, 305(22), 2335–2342.
Bockting, W. O., Miner, M. H., Swinburne Romine, R. E., Hamilton, A., & Coleman, E. (2013).

62
Stigma, mental health, and resilience in an online sample of the U.S. transgender
population. American Journal of Public Health, 103, 943–951.
Borgogna, N. C., McDermott, R. C., Aita, S. L., & Kridel, M. M. (2019). Anxiety and
Depression Across Gender and Sexual Minorities: Implications for Transgender, Gender
Nonconforming, Pansexual, Demisexual, Asexual, Queer, and Questioning
Individuals. Psychology of Sexual Orientation and Gender Diversity, 6(1), 54-63.
Bradford, J., Reisner, S. L., Honnold, J. A., & Xavier, J. (2013). Experiences of transgenderrelated discrimination and implications for health: Results from the Virginia transgender
health initiative study. American Journal of Public Health, 101(10), 1820-129.
Centers for Disease Control and Prevention (2020a, August 27). Guidance Documents. Retrieved
from https://www.cdc.gov/coronavirus/2019-ncov/communication/guidancelist.html?Sort=Date%3A%3Adesc
Centers for Disease Control and Prevention (2020b, September 11). How to protect yourself &
others. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/prevent-gettingsick/prevention.html
Céspedes, P., Sánchez-Martínez, V., Lera-Calatayud, G., Vila-Candel, R., Cauli, O., & Buigues,
C. (2020). Delay in the diagnosis of breast and colorectal cancer in people with severe
mental disorders. Cancer Nursing, 43(6), E356–E362.
Clements-Nolle, K., Marx, R., & Katz, M. (2006). Attempted suicide among transgender
persons: The influence of gender-based discrimination and victimization. Journal of
Homosexuality, 51, 53–69.
Coleman, E., Bockting, B., Cohen-Kettenis, D., Feldman, . . . Lev. (2012).
Standards of care for the health of transsexual, transgender, and gender-nonconforming

63
people, version 7. International Journal of Transgenderism, 13(4), 165-232.
Conron, K. J., Scott, G., Stowell, G. S., & Landers, S. J. (2012). Transgender health in
Massachusetts: Results from a household probability sample of adults. American Journal
of Public Health, 102(1), 118-22.
Cruz, T. M. (2014). Assessing access to care for transgender and gender nonconforming people:
A consideration of diversity in combating discrimination. Social Science & Medicine,
110, 65–73.
Derogatis, L. (2001). Brief Symptom Inventory 18, Administration and Scoring Manual.
Pearson, San Antonio, TX.
Dickey, L. M., & Budge, S. L. (2020). Suicide and the Transgender Experience: A Public Health
Crisis. The American Psychologist, 75(3), 380-390.
Dispenza, F., Watson, L. B., Chung, Y. B., & Brack, G. (2012). Experience of career‐related
discrimination for female‐to‐male transgender persons: A qualitative study. The Career
Development Quarterly, 60, 65–81.
Flentje, A., Heck, N. C., Brennan, J. M., & Meyer, I. H. (2019). The relationship between
minority stress and biological outcomes: A systematic review. Journal of Behavioral
Medicine, 43(5), 673-694.
Fredriksen-Goldsen, K. I., Simoni, J. M., Kim, H. J., Lehavot, K., Walters, K. L., Yang, J., . . .
Muraco, A. (2014). The health equity promotion model: Reconceptualization of lesbian,
gay, bisexual, and transgender (LGBT) health disparities. American Journal of
Orthopsychiatry, 84, 653–663.
Frost, D. M., & Meyer, I. H. (2009). Internalized homophobia and relationship quality among
lesbians, gay men, and bisexuals. Journal of Counseling Psychology, 56(1), 97-109.

64
Grant, J. M., Mottet, L. a, Tanis, J., Harrison, J., Herman, J. L., & Keisling, M. (2011). Injustice
at every turn: A report of the national transgender discrimination survey. Washington
National Center for Transgender Equality and National Gay and Lesbian Task Force.
https://doi.org/10.1016/S0016-7878(90)80026-2
Gonzales, G., Loret de Mola, E., Gavulic, K. A, McKay, T., & Purcell, C. (2020). Mental health
needs among lesbian, gay, bisexual, and transgender college students during the
covid-19 pandemic. Journal of Adolescent Health, 67(5), 645-648.
Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E.,…
Aggarwal, A. (2020). Mortality due to cancer treatment delay: Systematic review and
meta-analysis. BMJ, 371, m4087–m4087.
Hawke, L. D., Hayes, E., Darnay, K., & Henderson, J. (2021). Mental health among transgender
and gender diverse youth: An exploration of effects during the COVID-19
pandemic. Psychology of Sexual Orientation and Gender Diversity.
Hendricks, M. L., & Testa, R. J. (2012). A conceptual framework for clinical work with
transgender and gender nonconforming clients: An adaptation of the minority stress
model. Professional Psychology: Research and Practice, 43(5), 460-467.
Hunt, C., Gibson, G. C, Vander Horst, A., Cleveland, K. A., Wawrosch, C., Granot, M., …
Hughes, J. W. (2021). Gender diverse college students exhibit higher psychological
distress than male and female peers during the novel coronavirus (COVID-19)
pandemic. Psychology of Sexual Orientation and Gender Diversity.
Jaffee, K. D., Shires, D. A., & Stroumsa, D. (2016). Discrimination and delayed health care
among transgender women and men. Medical Care, 54, 1010–1016.
James, S., Herman, J., Rankin, S., Keisling, M., Mottet, L., & Anafi, M. (2016). The Report of

65
the 2015 US Transgender Survey. The Report of the 2015 US Transgender Survey.
Washington, DC: National Center for Transgender Equality.
Kattari, S., Atteberry-Ash, B., Kinney, M., Walls, N., & Kattari, L. (2019). One size
does not fit all: Differential transgender health experiences. Social Work in Health
Care, 58(9), 899-917.
Kidd, J. D., Jackman, K. B., Barucco, R., Dworkin, J. D., Dolezal, C., Navalta, T. V., …
Bockting, W. O. (2021). Understanding the impact of the COVID-19 pandemic on the
mental health of transgender and gender nonbinary individuals engaged in a longitudinal
cohort study. Journal of Homosexuality, 1–20.
Krieger, N. (2020). Measures of racism, sexism, heterosexism, and gender binarism for health
equity research: From structural injustice to embodied harm—An ecosocial analysis.
Annual Review of Public Health, 41, 37-62.
Langlands, A. O., Gebski, V., Hirsch, D., & Tattersall, M. H. N. (2002). Delay in the clinical
diagnosis of breast cancer: Estimating its effect on prognosis, with particular reference to
medical litigation. The Breast, 11(5), 386–393.
Lev, A. I. (2009). The ten tasks of the mental health provider: Recommendations for revision of
the world professional association for transgender health’s standards of care.
International Journal of Transgenderism, 11(2), 74-99.
Lykens, J. E., LeBlanc, A. J., & Bockting, W. O. (2018). Healthcare Experiences Among Young
Adults Who Identify as Genderqueer or Nonbinary. LGBT Health, 5(3), 191-196
Macapagal, K., Bhatia, R., & Greene, G. J. (2016). Differences in healthcare access, use, and
experiences within a community sample of racially diverse lesbian, gay, bisexual,
transgender, and questioning emerging adults. LGBT Health, 3(6), 434-442.

66
Martin, M. P., White, M. B., Hodgson, J. L., Lamson, A. L., & Irons, T. G. (2014). Integrated
Primary Care: A Systematic Review of Program Characteristics. Families Systems &
Health, 32(1), 101–115.
McCann, E., & Brown, M. (2017). Discrimination and resilience and the needs of people who
identify as transgender: A narrative review of quantitative research studies. In Journal of
Clinical Nursing, 26(23-24), 4080-4093.
Meerwijk, E. L., & Sevelius, J. M. (2017). Transgender population size in the united states: A
meta-regression of population-based probability samples. American Journal of Public
Health, 107(2), e1-e8.
Meyer, I. (2003). Prejudice, social stress, and mental health in lesbian, gay, and bisexual
populations: conceptual issues and research evidence. Psychological Bulletin, 129(5),
674-697.
Meyer, I. H. (2015). Resilience in the study of minority stress and health of sexual and gender
minorities. Psychology of Sexual Orientation and Gender Diversity, 2(3), 209–213.
Meyer, I. H. (2020). Rejection sensitivity and minority stress: A challenge for clinicians and
interventionists. Archives of Sexual Behavior, 49(7), 2287-2289.
Moore, S. E., Wierenga, K. L., Prince, D. M., Gillani, B., & Mintz, L. J. (2021).
Disproportionate impact of the COVID-19 pandemic on perceived social support, mental
health and somatic symptoms in sexual and gender minority populations. Journal of
Homosexuality, 1–15.
Palan, S., & Schitter, C. (2018). Prolific.ac—A subject pool for online experiments. Journal of
Behavioral and Experimental Finance, 7, 22-27.
Patallo, B. J. (2019). The multicultural guidelines in practice: Cultural humility in clinical

67
training and supervision. Training and Education in Professional Psychology, 13(3),
227–232.
Peer, E., Brandimarte, L., Samat, S., & Acquisti, A. (2017). Beyond the Turk: Alternative
platforms for crowdsourcing behavioral research. Journal of Experimental Social
Psychology, 70, 153-163.
Puckett, J. A., Cleary, P., Rossman, K., Mustanski, B., & Newcomb, M. E. (2018). Barriers to
gender‐affirming care for transgender and gender nonconforming individuals. Sexuality
Research and Social Policy, 15, 48–59.
Puckett, J. A., Matsuno, E., Dyar, C., Mustanski, B., & Newcomb, M. E. (2019). Mental Health
and Resilience in Transgender Individuals: What Type of Support Makes a
Difference? Journal of Family Psychology, 33(8), 954-964.
Puckett, J. A., Maroney, M. R., Wadsworth, L. P., Mustanski, B., & Newcomb, M. E. (2020).
Coping with discrimination: The insidious effects of gender minority stigma on
depression and anxiety in transgender individuals. Journal of Clinical Psychology, 76(1),
176-194.
Pyne, J. (2014). Gender independent kids: A paradigm shift in approaches to gender nonconforming children. The Canadian Journal of Human Sexuality, 23(1), 1-8.
Raphael, M. J., Biagi. J., Kong, W., Mates, M., Booth, C. M., & Mackillop, W. J. (2016). The
relationship between time to initiation of adjuvant chemotherapy and survival in breast
cancer: A systematic review and meta-analysis. Breast Cancer Research and
Treatment, 160(1), 17–28.
Rodriguez, A., Agardh, A., & Asamoah, B. O. (2017). Self-reported discrimination in health-care
settings based on recognizability as transgender: A cross-sectional study among

68
transgender U.S. citizens. Archives of Sexual Behavior, 47(4), 973-985.
Rood, B. A., Reisner, S. L., Surace, F. I., Puckett, J. A., Maroney, M. R., & Pantalone, D. W.
(2016). Expecting rejection: Understanding the minority stress experiences of transgender
and gender‐nonconforming individuals. Transgender Health, 1(1), 151–164.
Rotondi, N. K., Bauer, G. R., Travers, R., Travers, A., Scanlon, K., & Kaay, M. (2011).
Depression in male-to-female transgender Ontarians: Results from the Trans PULSE
Project. Canadian Journal of Commu- nity, 30, 113–133.
Salerno, J. P., Williams, N. D., & Gattamorta, K. A. (2020). LGBTQ Populations:
Psychologically Vulnerable Communities in the COVID-19 Pandemic. Psychological
Trauma, 12(S1), S239-S242
Seelman, K. L., Colón-Diaz, M. J. P., LeCroix, R. H., Xavier-Brier, M., & Kattari, L. (2017).
Transgender noninclusive healthcare and delaying care because of fear: Connections to
general health and mental health among transgender adults. Transgender Health, 2(1),
17-28.
Shires, D. A, & Jaffee, K. (2015). Factors Associated with Health Care Discrimination
Experiences among a National Sample of Female-to-Male Transgender
Individuals. Health & Social Work, 40(2), 134-141.
Staples, J. M., Neilson, E. C., Bryan, A. E., & George, W. H. (2018). The role of distal minority
stress and internalized transnegativity in suicidal ideation and nonsuicidal self‐injury
among transgender adults. The Journal of Sex Research, 55(4‐5), 591–603.
Tebbe, E. A., & Moradi, B. (2016). Suicide risk in trans individuals: An application of minority
stress theory. Journal of Counseling Psychology, 63(5), 520-533.
Testa, R. J., Habarth, J., Peta, J., Balsam, K., & Bockting, W. (2015). Development of the gender

69
minority stress and resilience measure. Psychology of Sexual Orientation and Gender
Diversity, 2(1), 65–77
Testa, R. J., Michaels, M. S., Bliss, W., Rogers, M. L., Balsam, K. F., & Joiner, T. (2017).
Suicidal ideation in transgender people: Gender minority stress and interpersonal theory
factors. Journal of Abnormal Psychology, 126(1), 125–136.
U.S. Census Bureau, Population Division (2019). Annual Estimates of the Resident Population
for the Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2019. Retrieved from
https://www.census.gov/programs-surveys/popest/data/tables.html
U.S. Equal Employment Opportunity Commission (2020, June 30). What you should know: The
eeoc and protections for lgbt workers. Retrieved March 23, 2021, from
https://www.eeoc.gov/laws/guidance/what-you-should-know-eeoc-and-protections-lgbtworkers
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., Ho, C., & Ho, Roger C. (2020). Immediate
Psychological Responses and Associated Factors during the Initial Stage of the 2019
Coronavirus Disease (COVID-19) Epidemic among the General Population in
China. International Journal of Environmental Research and Public Health, 17(5), 1729.
Watson, L. B., Allen, L. R., Flores, M. J., Serpe, C., & Farrell, M. (2019). The development and
psychometric evaluation of the trans discrimination scale: TDS‐21. Journal of Counseling
Psychology, 66, 14–29.
White Hughto, J. M., Reisner, S. L., & Pachankis, J. E. (2015). Transgender stigma and health: A
critical review of stigma determinants, mechanisms, and interventions. In Social Science
and Medicine, 147, 222-231.
Witten, T. M. (2014). End of life, chronic illness, and trans-identities. Journal of Social Work in

70
End-of-Life & Palliative Care, 10, 34–58.
World Health Organization (2020). Timeline of WHO’s response to covid-19. Retrieved from
https://www.who.int/news/item/29-06-2020-covidtimeline
Zappa, A. (2017). Beyond Erasure: The Ethics of Art Therapy Research With Trans and GenderIndependent People. Art Therapy, 34(3), 129-134.
Zhang, J., Fang, L., Wu, X., Liu, J., Zhang, C., & Dai, D. (2015). Factors associated with
delaying medical assessment of patients and impacting the prognosis of rectal
cancer. European Journal of Cancer Prevention, 24(5), 391–399

71
Appendix A.
RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM
STUDY TITLE: Discrimination and Health in Gender Minority Individuals
VCU INVESTIGATOR: Eric Benotsch, Ph.D.
You are being invited to participate in a research study.
Your participation is voluntary. You may decide not to participate in this study. If you do
participate, you may withdraw from the study at any time. Your decision not to take part or to
withdraw will involve no penalty. You may print out a copy of this sheet to keep.
Why is this study being done?
The purpose of this research study is to learn more about discrimination experiences and health
behaviors in gender minority individuals.

What will happen if I participate?
In this study you will be asked to complete a questionnaire. The questionnaire asks about
discrimination experiences, resiliency factors, stress, loneliness, psychiatric symptoms, substance
use, use of health care services, and demographic information. Additional questions will ask
about the impact the coronavirus (COVID-19) pandemic has had on your life. There are also
questions that check if you are paying attention. You will need to answer these questions
correctly to receive payment.
The survey will take about 10 minutes to complete.
What are the risks and benefits of participating?
Sometimes answering questions about these subjects causes people to become upset. Some
questions will ask about private things like substance use. You do not have to answer any
questions you do not want to answer and you may leave the study at any time. Participation in
research might involve some loss of privacy. We will not ask your name or any other
information that will identify you, but there is a small risk that someone outside the research
study could see and misuse information about you.
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WILL I BE PAID TO PARTICIPATE IN THE STUDY?
You will be paid $1.20 to participate in the study.
CAN I STOP BEING IN THE STUDY?
You can stop being in this research study at any time.
HOW WILL INFORMATION ABOUT ME BE PROTECTED?
VCU has established secure research databases and computer systems to store information and to
help with monitoring and oversight of research. Your information may be kept in these databases
but are only accessible to individuals working on this study or authorized individuals who have
access for specific research related tasks.
WHOM SHOULD I CONTACT IF I HAVE QUESTIONS ABOUT THE STUDY?
The investigator named below is the best person(s) to contact if you have any questions,
complaints, or concerns about your participation in this research:

Eric Benotsch, 804-828-0133 or ebenotsch@vcu.edu

If you have general questions about your rights as a participant in this or any other research, or if
you wish to discuss problems, concerns or questions, to obtain information, or to offer input
about research, you may contact:
Virginia Commonwealth University Office of Research
800 East Leigh Street, Suite 3000, Box 980568, Richmond, VA 23298
(804) 827-2157; https://research.vcu.edu/human_research/volunteers.htm
Do not consent unless you have had a chance to ask questions and have received satisfactory
answers to all of your questions.
Please indicate if you consent to participate:
_I consent and wish to take part in the study.
_I do NOT consent and wish to withdraw
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Appendix B.
SURVEY MEASURE
Please indicate how much you agree with the following statements:

I feel part of a community of
people who share my gender
identity.
I feel connected to other people
who share my gender identity.
When interacting with
members of the community
who share my gender identity, I
feel like I belong.
I’m not like other people who
share my gender identity.
I feel isolated and separate
from other people who share
my gender identity.
Please select neither agree nor
disagree for this item.

Strongly
Disagree

Disagree

Agree

Strongly
Agree

1

Neither
agree nor
disagree
2

0

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

Testa et al, 2015. (Community Connectedness subscale of Gender Minority Stress and
Resilience Measure).
Derogatis, 2001 (Depression and Anxiety subscales of Brief Symptom Inventory)
Please check the number of the response that best describes how much that problem has
bothered you in the past 7 days, including today:
In the past 7 days, how much
Not at all
A little bit Moderately Quite a bit
were you distressed by:
Feeling no interest in things
0
1
2
3
Nervousness or shaking inside
0
1
2
3
Feeling lonely
0
1
2
3
Feeling tense or keyed up
0
1
2
3
Feeling blue
0
1
2
3
Suddenly scared for no reason
0
1
2
3
Feelings of worthlessness
0
1
2
3
Spells of terror or panic
0
1
2
3
Feeling hopeless about the future
0
1
2
3
Feeling so restless you couldn’t sit
0
1
2
3
still

Extremely
4
4
4
4
4
4
4
4
4
4
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Please select “a little bit” for this
item.
Thoughts of ending your life
Feeling fearful

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

Hays & DiMatteo, 1987. (8-item UCLA loneliness scale)
Please indicate how often you feel the way described in each of the following statements:
I lack companionship.
There is no one I can turn to.
I am an outgoing person.
I feel left out.
I feel isolated from others.
I can find companionship when I
want it.
I am unhappy being so withdrawn.
People are around me but not with
me.

Never
Never
Never
Never
Never
Never
Never

Rarely
Rarely
Rarely
Rarely
Rarely
Rarely
Rarely

Sometimes
Sometimes
Sometimes
Sometimes
Sometimes
Sometimes
Sometimes

Often
Often
Often
Often
Often
Often
Often

Never
Never

Rarely
Rarely

Sometimes
Sometimes

Often
Often

The questions in this scale ask about your feelings and thoughts during THE LAST
MONTH. In each case, please indicate by checking HOW OFTEN you felt or thought a
certain way. (Cohen & Williamson, 1988. Perceived Stress Scale - 4)
Never
In the last month, how often have you felt that you
were unable to control the important things in your
life?
In the last month, how often have you felt
confident about your ability to handle your
personal problems?
In the last month, how often have you felt things
were going your way?
In the last month, how often have you felt
difficulties were piling up so high that you could
not overcome them?

Sometimes

0

Almost
Never
1

2

Fairly
Often
3

Very
Often
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4
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Benotsch et al, 2013, 2015
Please indicate how much you have used the following in the past 3 months:

Alcohol
Cigarettes/Cigars
E-cigarettes/Juul/Evaporizor
Marijuana/Cannabis/Pot
Ecstasy
Methamphetamine
Cocaine (powder or
crack)
Club drugs (e.g.,
Ketamine/”Special K”,
Poppers/”Rush”, GHB,
Rohypnol/”roofies”)
Heroin
Any other recreational
drugs (list)
___________________

None

Once or Twice

Several Times

1
1
1

2
2
2

3
3
3

At least every
week
4
4
4

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

1

2

3

4

1
1

2
2

3
3

4
4
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Miech et al., 2018 (Items adapted from Monitoring the Future study)
To "vape" is to use a device such as a vape-pen, an e-cigarette, an e-hookah, or e-vaporizer to
inhale a mist into the lungs. Have you ever vaped, even once in your lifetime?
Yes

No

(If no, skip the rest of the questions on this page)
(If Yes)
On how many occasions (if any) have you vaped NICOTINE in your lifetime?
0 Occasions 1-2 Occasions
3-5 Occasions
20-39 Occasions
40 or More Occasions

6-9 Occasions 10-19 Occasions

On how many occasions (if any) have you vaped MARIJUANA in your lifetime?
0 Occasions 1-2 Occasions
3-5 Occasions
20-39 Occasions
40 or More Occasions

6-9 Occasions 10-19 Occasions

On how many occasions (if any) have you vaped NICOTINE during the last 3 months?
0 Occasions 1-2 Occasions
3-5 Occasions 6-9 Occasions
20-39 Occasions
40 or More Occasions

10-19 Occasions

On how many occasions (if any) have you vaped MARIJUANA during the last 3 months?
0 Occasions 1-2 Occasions
3-5 Occasions 6-9 Occasions
20-39 Occasions
40 or More Occasions

10-19 Occasions
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Benotsch et al, 2013, 2015
In your lifetime, have you ever used a prescription medication (e.g., Vicodin, Xanax)
WITHOUT a doctor’s prescription?
Yes

No

(If No, skip the rest of the questions on this page)
(If Yes)
Please indicate how much you have used the following in the past 3 months:

Pain Medications /
Opioids
(e.g., Oxycontin,
Vicodin)
WITHOUT a doctor’s
prescription
Sedatives (e.g.,
Restoril, Ambien)
WITHOUT a doctor’s
prescription
Anxiety Medications
(e.g., Xanax, Valium)
WITHOUT a doctor’s
prescription
Stimulants (e.g.,
Ritalin, Adderall)
WITHOUT a doctor’s
prescription

None

Once or Twice

Several Times

1

2

3

At least every
week
4

1

2

3

4

1

2

3

4

1

2

3

4

In your lifetime, have you ever used alcohol at the same time as prescription medication used
without a doctor’s prescription?
Yes
No
In your lifetime, have you ever used recreational drugs (e.g., ecstasy, cocaine) at the same time
as prescription medication used without a doctor’s prescription?
Yes
No
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On March 11, 2020, the World Health Organization declared that the coronavirus (COVID-19)
outbreak had reached pandemic status. Since the start of the coronavirus pandemic, has the
amount of substances you use changed?
No
Yes
(If Yes) How has your use of substances changed since the start of the coronavirus pandemic?
It has increased a lot
It has increased somewhat
It has increased slightly
It has decreased slightly
It has decreased somewhat
It has decreased a lot
In this section gender expression means how masculine/feminine/androgynous one appears
to the world based on many factors such as mannerisms, dress, personality, etc. Testa et al,
2015.
Please check all that apply (for example you may check both “yes, after age 18” and “in the
past year” if both are true for you).
Never
Yes, before age
Yes, after
Yes, in
18
age 18
the past
year
I have had difficulty getting
medical or mental health treatment
(transition-related or other)
because of my gender identity or
expression.
Because of my gender identity or
expression, I have had difficulty
finding a bathroom to use when I
am out in public.
I have experienced difficulty
getting identity documents that
match my gender identity.
I have had difficulty finding
housing or staying in housing
because of my gender identity or
expression.
I have had difficulty finding
employment or keeping
employment, or have been denied
promotion because of my gender
identity or expression.
(Gender-Related Discrimination subscale of Gender Minority Stress and Resilience
Measure).
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The next section asks some additional questions about the coronavirus (COVID-19) pandemic.
(Wang et al., 2020)
Where do you receive information about COVID-19? Check all that apply
o Television
o Online News Media
o Social Media
o Government website
o Family or friends
o Other sources (please specify)
How often do you receive information on COVID-19?
• Less than once a week
• Multiple times a week
• Daily
• Multiple times a day
(If selected “social media” in first question on this page).
How often do you see memes that have health information about COVID-19 in them?
• Less than once a week
• Multiple times a week
• Daily
• Multiple times a day
How satisfied are you with the amount of health information available about the coronavirus
(COVID-19)?
1. Not satisfied at all
2. Not very satisfied
3. Somewhat satisfied
4. Very satisfied
5. Do not know
Have you been told by a health care provider that you had the coronavirus (COVID-19)?
Yes

No

(If No, ask next two questions)
Have you had symptoms that might have been the coronavirus (COVID-19) such as fever,
cough, sore throat, difficulty breathing, or less of smell in the last 3 months but you weren’t
tested?
Yes

No
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How would you rate your likelihood of contracting the coronavirus (COVID-19) during the
current outbreak?
1. Not at all likely
2. Not very likely
3. Somewhat likely
4. Very likely
5. Do not know
Adapted from Coronavirus Anxiety Scale (CAS) Lee, S. A. (2020). Coronavirus anxiety scale: A
brief mental health screener for COVID-19 related anxiety. Death Studies, 1-9.
How often have you experienced the
following over the last 7 days, including
today?
I felt dizzy, lightheaded or faint, when I
read or listened to news about the
coronavirus.
I had trouble falling or staying asleep
because I was thinking about the
coronavirus.
I felt paralyzed or frozen when I thought
about or was exposed to information
about the coronavirus.
Please select “a little bit” for this item.
I used alcohol or other drugs to help me
get through the fear and/or anxiety
caused by the coronavirus.

Not
at all

A little
bit

Moderately Quite
a bit

Extremely

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

To date, about how many people have died due to the coronavirus (COVID-19) in the United
States?
Please provide your best estimate:
Since the start of the coronavirus pandemic, how much have you engaged in social / physical
distancing?
None
Some of the time
Most of the time
All of the time
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In the last month, how much have you engaged in social / physical distancing?
None
Some of the time
Most of the time
All of the time
Have any of these things happened to you, as a trans / gender non-conforming person, when you
went to see a doctor or health care provider? Please check all that apply (for example you
may check both “yes, after age 18” and “in the past year” if both are true for you). (Items
adapted from 2015 Transgender Survey. James et al. (2016).)
Never
Yes, before age Yes, after
Yes, in the
18
age 18
past year
I had to teach a doctor or other
health care provider about
trans/gender non-conforming
people so that I could get
appropriate care.
A doctor or other health care
provider refused to give me
trans/gender non-conformingrelated care.
A doctor or other health care
provider refused to give me other
health care (such as physical exam,
flu, diabetes).
A doctor asked me
unnecessary/invasive questions
about my trans/gender nonconforming status that were not
related to the reason for my visit.
A doctor or other health care
provider used harsh or abusive
language when treating me.
I was verbally harassed in a health
care setting (such as hospital,
office, clinic).
A doctor or other health care
provider refused to use the
pronouns or name that I requested
to be used.
The medical forms or documents
that a doctor or other health care
provider asked me to complete did
not include my gender identity.
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Was there a time in the past 12 months when you needed to see a doctor but could not because
of cost?
Yes
No
Was there a time in the past 12 months when you needed to see a doctor but did not because you
thought you would be disrespected or mistreated as a trans/gender non-conforming person?
Yes
No
Since the start of the coronavirus pandemic (3/11/20), was there a time when you needed to
see a doctor but could not because of cost?
Yes
No
Was there a time since the start of the coronavirus pandemic when you needed to see a doctor
but did not because you thought you would be disrespected or mistreated as a trans/gender nonconforming person?
Yes
No
Was there a time since the start of the coronavirus pandemic, when you needed to see a doctor
but did not because you were worried about being exposed to the coronavirus in a health care
setting?
Yes
No
(If Yes) What symptoms were you experiencing? ____________________________________
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What is your age? ___________ years
What was your sex identified at birth?

Male Female

How do you identify your gender now?

Man
(Check all that apply)
Woman
Trans Man
Trans Woman
Non-binary
Genderqueer
Gender non-conforming
Gender fluid
Another identity not listed______________

What state do you live in? (drop-down menu of states):
Which best describes you? (check all that apply)
Black/African-American
Asian/Asian-American
Hispanic/Latino(a)
Native American
White
Another identity not listed___________
What is your highest level of formal education?
Middle school
High school
GED
Vocational school
Associate’s Degree
Bachelor’s Degree
Graduate Degree (Master’s, Doctorate, etc.)
What is your employment status? (check all that apply)
Employed full time
Employed part time
Student
Retired
On disability
Unemployed
Other____________
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Has your employment situation changed since the start of the coronavirus pandemic (3/11/20)?
Yes
No
(If Yes) How has your employment situation changed since the coronavirus pandemic? (check
all that apply)
Lost my job
Had my hours and/or pay reduced
Had my hours and/or pay increased
Was previously unemployed but now have a job
I am now working remotely
Other__________________
In the past year where have you primarily lived?
University housing
Alone in Non-University housing
With my partner
With friends / roommates
With my parents / siblings
In a shelter or experiencing housing instability
Another housing/living arrangement not listed________
Since the start of the coronavirus pandemic has where you live changed?
Yes
No
(If yes)
Since the start of the coronavirus pandemic where have you primarily lived?
University housing
Alone in Non-University housing
With my partner
With friends / roommates
With my parents / siblings
In a shelter or experiencing housing instability
Another housing/living arrangement not listed________
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Which best describes you?
Heterosexual/Straight
Homosexual/Gay
Bisexual
Pansexual
Asexual
Another identity not listed_________
To what degree are you open (out) with your transgender identity in your personal / social life
including with friends and family?
1 None of the time
2
3
4
5
6
7 All of the time
To what degree are you open (out) with your transgender identity in your work / professional life
including with coworkers or classmates?
1 None of the time
2
3
4
5
6
7 All of the time
(Adapted from Transgender Identity Survey, Bockting et al., 2020)

Do you currently have health insurance?
Yes
No
(If Yes)
What type of health insurance do you have?
Private Insurance (Includes: Plans through employers, federal employee plans, plans from the
Marketplace, plans through parents or partners, plans through universities)
Public Insurance (Includes: Military insurance (Tricare), Medicaid, Medicare, Veteran’s
benefits)
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Are any of your daily activities limited in any way because of your physical, mental, or
emotional health?
Yes
No
Don’t Know
Do you use any assistive equipment or technologies, such as a mobility device, a wheelchair, a
special bed, a screen reader, or captioning software?
Yes
No
Don’t Know
Do you identify as disabled and/or neurodivergent?
Yes
No
What is your household annual income?
__ $0 - $20,000
__ $20,001 - $40,000
__ $40,001 - $60,000
__ $60,001 - $80,000
__ $80,001 - $100,000
__ More than $100,000
Please let us know if you have any feedback about this study. If you do not have feedback, you
can skip this question and click the following link to be redirected back to the Prolific site.
______________________________________________________________________________

